<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">88828</article-id><article-id pub-id-type="doi">10.7554/eLife.88828</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Atypical peripheral actin band formation via overactivation of RhoA and nonmuscle myosin II in mitofusin 2-deficient cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-316580"><name><surname>Wang</surname><given-names>Yueyang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5445-8186</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316581"><name><surname>Troughton</surname><given-names>Lee D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316582"><name><surname>Xu</surname><given-names>Fan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6298-5587</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316583"><name><surname>Chatterjee</surname><given-names>Aritra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5318-3459</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200905"><name><surname>Ding</surname><given-names>Chang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316584"><name><surname>Zhao</surname><given-names>Han</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316585"><name><surname>Cifuentes</surname><given-names>Laura P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316586"><name><surname>Wagner</surname><given-names>Ryan B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4111-8027</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200903"><name><surname>Wang</surname><given-names>Tianqi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334685"><name><surname>Tan</surname><given-names>Shelly</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-124861"><name><surname>Chen</surname><given-names>Jingjuan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316587"><name><surname>Li</surname><given-names>Linlin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9667-2965</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71755"><name><surname>Umulis</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1913-2284</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48984"><name><surname>Kuang</surname><given-names>Shihuan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9180-3180</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291323"><name><surname>Suter</surname><given-names>Daniel M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5230-7229</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-316588"><name><surname>Yuan</surname><given-names>Chongli</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3765-0931</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-191851"><name><surname>Chan</surname><given-names>Deva</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1508-1045</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-137012"><name><surname>Huang</surname><given-names>Fang</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159760"><name><surname>Oakes</surname><given-names>Patrick W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9951-1318</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-83735"><name><surname>Deng</surname><given-names>Qing</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9254-9951</contrib-id><email>deng67@purdue.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Department of Biological Sciences, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04b6x2g63</institution-id><institution>Cell and Molecular Physiology, Loyola University Chicago</institution></institution-wrap><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Weldon School of Biomedical Engineering, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01skt4w74</institution-id><institution>Advanced Research Institute of Multidisciplinary Science, Beijing Institute of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Davidson School of Chemical Engineering, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>School of Mechanical Engineering, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Department of Animal Sciences, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Department of Agricultural and Biological Engineering, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Purdue Institute for Integrative Neuroscience, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Purdue Institute for Inflammation, Immunology &amp; Infectious Disease, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02dqehb95</institution-id><institution>Purdue University Center for Cancer Research, Purdue University West Lafayette</institution></institution-wrap><addr-line><named-content content-type="city">West Lafayette</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>19</day><month>09</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e88828</elocation-id><history><date date-type="received" iso-8601-date="2023-04-21"><day>21</day><month>04</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-09-19"><day>19</day><month>09</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-10-04"><day>04</day><month>10</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.03.510661"/></event></pub-history><permissions><copyright-statement>© 2023, Wang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Wang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-88828-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-88828-figures-v2.pdf"/><abstract><p>Cell spreading and migration play central roles in many physiological and pathophysiological processes. We have previously shown that MFN2 regulates the migration of human neutrophil-like cells via suppressing Rac activation. Here, we show that in mouse embryonic fibroblasts, MFN2 suppresses RhoA activation and supports cell polarization. After initial spreading, the wild-type cells polarize and migrate, whereas the <italic>Mfn2<sup>-/-</sup></italic> cells maintain a circular shape. Increased cytosolic Ca<sup>2+</sup> resulting from the loss of Mfn2 is directly responsible for this phenotype, which can be rescued by expressing an artificial tether to bring mitochondria and endoplasmic reticulum to close vicinity. Elevated cytosolic Ca<sup>2+</sup> activates Ca<sup>2+</sup>/calmodulin-dependent protein kinase II, RhoA, and myosin light-chain kinase, causing an overactivation of nonmuscle myosin II, leading to a formation of a prominent F-actin ring at the cell periphery and increased cell contractility. The peripheral actin band alters cell physics and is dependent on substrate rigidity. Our results provide a novel molecular basis to understand how MFN2 regulates distinct signaling pathways in different cells and tissue environments, which is instrumental in understanding and treating MFN2-related diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cell spreading</kwd><kwd>cell migration</kwd><kwd>mitochondrial-ER tether</kwd><kwd>Rho GTPase</kwd><kwd>calcium signaling</kwd><kwd>mouse embryonic fibroblasts</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM119787</award-id><principal-award-recipient><name><surname>Deng</surname><given-names>Qing</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R35GM119785</award-id><principal-award-recipient><name><surname>Huang</surname><given-names>Fang</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM132501</award-id><principal-award-recipient><name><surname>Umulis</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P30CA023168</award-id><principal-award-recipient><name><surname>Deng</surname><given-names>Qing</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>2120200</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Deva</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006377</institution-id><institution>Purdue University</institution></institution-wrap></funding-source><award-id>Bisland Fellowship</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Yueyang</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mfn2 depletion upregulates cytosolic Ca<sup>2+</sup> in mouse fibroblast cells, leading to RhoA and nonmuscle myosin II overactivation and a prominent peripheral actin band structure, which is dependent on the contractile force on the cell–substrate interface.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cell spreading and migration play central roles in numerous physiological and pathophysiological processes. The dynamic cytoskeletal reorganization during cell migration is primarily achieved through a delicate balance between protrusive and retractive forces. The cytoskeleton and regulatory proteins cooperate with spatial and temporal precision to organize cell contents to control protrusions, adhesion, contractility, and force transmission (<xref ref-type="bibr" rid="bib55">Lauffenburger and Horwitz, 1996</xref>; <xref ref-type="bibr" rid="bib75">Pollard and Borisy, 2003</xref>; <xref ref-type="bibr" rid="bib82">Seetharaman and Etienne-Manneville, 2020</xref>). The cytoskeletal networks are controlled by master regulators, such as the small Rho GTPases (<xref ref-type="bibr" rid="bib63">Nobes and Hall, 1995</xref>; <xref ref-type="bibr" rid="bib87">Takai et al., 1995</xref>; <xref ref-type="bibr" rid="bib45">Kaibuchi et al., 1999</xref>). The initial cell spreading is driven by actin polymerization promoted by Rac1 and Cdc42 to form a sheet-like protrusion that generates a pushing force at the cell’s leading edge. Subsequently, Ras homolog gene family member A (RhoA) and calcium/calmodulin (CaM)-dependent pathways modulate myosin-dependent contractile force by regulating focal adhesions (<xref ref-type="bibr" rid="bib76">Ridley and Hall, 1992</xref>; <xref ref-type="bibr" rid="bib64">Nobes and Hall, 1999</xref>; <xref ref-type="bibr" rid="bib63">Nobes and Hall, 1995</xref>) and inducing the formation of actin-myosin filaments, which form stress fibers (<xref ref-type="bibr" rid="bib76">Ridley and Hall, 1992</xref>; <xref ref-type="bibr" rid="bib2">Amano et al., 1996</xref>). Reduced activity of RhoA is necessary for spreading and migration, which facilitates cell edge extension by reducing myosin-dependent contractile forces (<xref ref-type="bibr" rid="bib99">Wakatsuki et al., 2003</xref>). Myosin, specifically nonmuscle myosin II (NMII), functions as a master regulator of cell stiffness, further influencing cell migration (<xref ref-type="bibr" rid="bib88">Tee et al., 2011</xref>). Notably, in addition to generating mechanical force within a cell, NMII plays an essential role in sensing and responding to external forces applied to the cell (<xref ref-type="bibr" rid="bib97">Vicente-Manzanares et al., 2009</xref>; <xref ref-type="bibr" rid="bib1">Aguilar-Cuenca et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Lamb et al., 2021</xref>).</p><p>Fibroblasts are mesenchyme-derived cells essential for tissue development and repair by remodeling the extracellular matrix. Additionally, they secrete multiple growth factors and respond to migratory cues such as PDGF (<xref ref-type="bibr" rid="bib102">Wynn, 2008</xref>). As a widely used cell model, the in vitro motility of fibroblasts has been extensively studied. Local Ca<sup>2+</sup> pulses play critical roles in migrating cells, including fibroblasts, and Ca<sup>2+</sup> homeostasis controls the organization of the cytoskeleton spatially and temporally (<xref ref-type="bibr" rid="bib7">Bennett and Weeds, 1986</xref>; <xref ref-type="bibr" rid="bib93">Tsai et al., 2015</xref>; <xref ref-type="bibr" rid="bib92">Tsai and Meyer, 2012</xref>). The intracellular Ca<sup>2+</sup> signals are predominantly generated from the intracellular Ca<sup>2+</sup> storage, the endoplasmic reticulum (ER), through inositol triphosphate (IP3) receptors (<xref ref-type="bibr" rid="bib16">Clapham, 2007</xref>; <xref ref-type="bibr" rid="bib72">Parys and De Smedt, 2012</xref>). Calmodulin (CaM) is an essential effector protein in cells to amplify the Ca<sup>2+</sup> signaling (<xref ref-type="bibr" rid="bib16">Clapham, 2007</xref>). The Ca<sup>2+</sup>/calmodulin (CaM)-dependent pathways promote the phosphorylation of the myosin light chain (MLC), promoting the formation of adhesive contacts and stress fibers (<xref ref-type="bibr" rid="bib46">Kamm and Stull, 1985</xref>; <xref ref-type="bibr" rid="bib85">Stull et al., 1998</xref>). In addition, Ca<sup>2+</sup>/CaM activates Ca<sup>2+</sup>/CaM kinases (CaMKs), including CaMKI, CaMKK, and CaMKII (<xref ref-type="bibr" rid="bib80">Saneyoshi and Hayashi, 2012</xref>; <xref ref-type="bibr" rid="bib83">Soderling, 1999</xref>; <xref ref-type="bibr" rid="bib39">Hudmon and Schulman, 2002</xref>), each regulates actin cytoskeleton in distinct pathways (<xref ref-type="bibr" rid="bib80">Saneyoshi and Hayashi, 2012</xref>). Notably, CaMKII bundles F-actin to remodel the cytoskeleton (<xref ref-type="bibr" rid="bib57">Lin and Redmond, 2008</xref>; <xref ref-type="bibr" rid="bib67">Okamoto et al., 2007</xref>; <xref ref-type="bibr" rid="bib68">O’Leary et al., 2006</xref>) and regulates Rho GTPases, including Rac and RhoA, by phosphorylating their GEFs and GAPs (<xref ref-type="bibr" rid="bib29">Fleming et al., 1999</xref>; <xref ref-type="bibr" rid="bib66">Okabe et al., 2003</xref>; <xref ref-type="bibr" rid="bib89">Tolias et al., 2005</xref>; <xref ref-type="bibr" rid="bib103">Xie et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Penzes et al., 2008</xref>).</p><p>Mitochondria are central cellular power stations. In addition, they regulate many physiological processes, such as maintaining intracellular Ca<sup>2+</sup> homeostasis and cell migration (<xref ref-type="bibr" rid="bib20">Denisenko et al., 2019</xref>; <xref ref-type="bibr" rid="bib12">Campello et al., 2006</xref>; <xref ref-type="bibr" rid="bib106">Zhao et al., 2013</xref>; <xref ref-type="bibr" rid="bib6">Báthori et al., 2006</xref>). The mitofusins (MFN1 and MFN2) localize to the outer mitochondrial membrane (OMM) and form homo- or heterodimers to promote mitochondrial outer membrane tethers (<xref ref-type="bibr" rid="bib81">Santel and Fuller, 2001</xref>; <xref ref-type="bibr" rid="bib14">Chen et al., 2003</xref>). Human MFN1 and MFN2 share ~80% similarity in protein sequence. They contain a large, cytosolic, N-terminal GTPase domain, two coiled-coil heptad-repeat (HR) domains, and two transmembrane domains (TM) crossing the OMM. MFN1 and MFN2 have primarily overlapping functions. Overexpression of either protein in MFN1 or MFN2 null cells promotes mitochondrial fusion (<xref ref-type="bibr" rid="bib14">Chen et al., 2003</xref>). Knocking out either MFN1 or MFN2 leads to fragmented mitochondria in fibroblasts (<xref ref-type="bibr" rid="bib14">Chen et al., 2003</xref>; <xref ref-type="bibr" rid="bib15">Cipolat et al., 2004</xref>). Structural and biochemical studies revealed the difference between MFN1 and MFN2 in catalytic GTPase activity (<xref ref-type="bibr" rid="bib42">Ishihara et al., 2004</xref>; <xref ref-type="bibr" rid="bib24">Efremov et al., 2019</xref>) and in their ability to mediate trans-organelle calcium signaling (<xref ref-type="bibr" rid="bib23">Dorn, 2020</xref>; <xref ref-type="bibr" rid="bib62">Naon et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">de Brito and Scorrano, 2008</xref>). MFN2, but not MFN1, localizes to the mitochondria-associated ER membranes (MAM) (<xref ref-type="bibr" rid="bib18">de Brito and Scorrano, 2008</xref>; <xref ref-type="bibr" rid="bib27">Filadi et al., 2015</xref>). Mfn2 ablation in various cell types increases the distance between the ER and mitochondria and severely reduces Ca<sup>2+</sup> transfer from the ER to mitochondria (<xref ref-type="bibr" rid="bib18">de Brito and Scorrano, 2008</xref>; <xref ref-type="bibr" rid="bib27">Filadi et al., 2015</xref>; <xref ref-type="bibr" rid="bib62">Naon et al., 2016</xref>). Investigation of MFN2’s role in human diseases has primarily focused on MFN-mediated mitochondrial fusion, trafficking, metabolism, mitophagy, and mitochondrial quality control. How MFNs regulate the cytoskeleton, however, remains unclear.</p><p>In our previous research to understand the importance of mitochondrial shape in neutrophil migration, we generated transgenic zebrafish lines with CRISPR-based neutrophil-specific knockout of mitochondrial fusion-related genes (<xref ref-type="bibr" rid="bib60">Maianski et al., 2002</xref>; <xref ref-type="bibr" rid="bib107">Zhou et al., 2018</xref>). Surprisingly, we noticed a phenotype specific to Mfn2 deletion: most neutrophils exited the hematopoietic tissue and circulated in the bloodstream in homeostasis. We further demonstrated that MFN2 regulates neutrophil adhesive migration and Rac activation using the human neutrophil-like differentiated HL-60 cells (<xref ref-type="bibr" rid="bib108">Zhou et al., 2020</xref>). Although we identified an essential role for MFN2 in neutrophil adhesion and migration, it is unclear how MFN2 regulates actin cytoskeleton organization and other cellular behaviors, such as cell spreading.</p><p>Here, we used mice embryonic fibroblasts (MEFs) as a model to further characterize how MFN2 regulates cytoskeletal organization. We demonstrate that MFN2 regulates cytoskeletal organization by suppressing Rho and NMII activity. <italic>Mfn2</italic> depletion upregulates cytosolic Ca<sup>2+</sup> in MEFs, leading to RhoA and NMII overactivation and forming a prominent ‘peripheral actin band (PAB)’ structure. This PAB hampered cell adhesive migration and caused significant changes in mechanical properties, including cell stiffness and membrane tension. Together, our results provided an in-depth molecular understanding of the role of MFN2 in cytoskeleton dynamics, cell spreading, and adhesive migration, which may lead to a better understanding and treatment of MFN2-associated diseases.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>MFN2 deficiency changes cell morphology and impairs adhesive 2D random migration in MEFs</title><p>As a first step in investigating the role of MFN2 in MEF cells, we confirmed the respective protein loss in indicated cell lines by immunoblotting (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We first analyzed the morphology and spread area of the cells in the culture. We found that the average cell spread area was reduced significantly in <italic>Mfn2</italic>-null MEFs (1303 µm<sup>2</sup>) compared to <italic>wt</italic> (2233 µm<sup>2</sup>) and <italic>Mfn1</italic>-null MEFs (2350 µm<sup>2</sup>) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>Mfn2</italic>-null MEFs also displayed significantly increased cell circularity (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). To evaluate the function of MFN2 protein in the cytoskeleton and cell migration, we seeded the cells on chamber slides. We imaged them overnight using phase-contrast, time-lapse microscopy. In <italic>Mfn2</italic>-null MEFs, cell motility (0.23 ± 0.08 µm/min) was significantly reduced compared to <italic>wt</italic> (0.53 ± 0.16 µm/min) or <italic>Mfn1</italic>-null MEFs (0.49 ± 0.12 µm/min) (<xref ref-type="fig" rid="fig1">Figure 1D–F</xref>, <xref ref-type="video" rid="video1">Video 1</xref>). No significant change in directionality was observed in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). During cell spreading, <italic>wt</italic> and <italic>Mfn1</italic>-null MEFs generated rapid protrusive filopodia and lamellipodia, eventually elongating to form traditional fibroblast-like shapes and began to migrate. However, the elimination of MFN2 caused significant defects in elongation, and the cells remained rounded (<xref ref-type="fig" rid="fig1">Figure 1H and I</xref>). The morphological differences became apparent during the spreading process, especially after 20 mins. <italic>Mfn2</italic>-null MEFs only extended round membrane ruffles but did not simultaneously form multiple short lamellae separated by concave edges. Immunofluorescence also revealed striking differences in actin stress fiber organization. Both <italic>wt</italic> and <italic>Mfn1</italic>-null MEFs displayed parallel stress fibers in the cell body, while <italic>Mfn2</italic>-null MEFs contained an enrichment in actin filaments in the cell cortex with reduced stress fibers at the center of the cells (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). To rule out the possibility of side effects caused by long-term culture, we isolated MEFs from <italic>Mfn2<sup>flox/flox</sup></italic> mice. The addition of Cre-expressing adenovirus induced loss of MFN2 within 48 hr, reproduced the rounded morphology, and altered actin cytoskeleton organization seen in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B–D</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>MFN2 regulates random migration and spreading in mice embryonic fibroblasts (MEFs).</title><p>(<bold>A</bold>) Western blot determining the expression levels of MFN1 and MFN2 in wt, Mfn2-null, and Mfn1-null MEFs. (<bold>B, C</bold>) Spread area (<bold>B</bold>) and circularity (<bold>C</bold>) of wt, Mfn1-null, and Mfn2-null MEFs after overnight culture. The individual points represent individual MEF cells. (<bold>D–G</bold>) representative images with individual tracks (<bold>D</bold>), Wind–Rose plots (<bold>E</bold>), quantification of velocity (<bold>F</bold>), and directionality (<bold>G</bold>) of wt, Mfn1-null, and Mfn2-null MEFs cells during random migration. (<bold>H, I</bold>) Quantification of cell circularity (<bold>H</bold>) and representative images (<bold>I</bold>) of indicated MEFs during cell spreading at indicated time points. Data are presented as mean ± SD in (<bold>F</bold>) and were pooled from a total of 18 cells in three independent experiments. Bars represent arithmetic means ± SD. One representative result of three biological repeats is shown in (<bold>A, D, E, I</bold>). Data are pooled from three independent experiments in (<bold>B, C, F, G</bold>). n = 50 cells are tracked and counted in (<bold>B, C</bold>). N = 30 cells are quantified in (<bold>D</bold>). ****p&lt;0.0001 (one-way ANOVA). Scale bars: 50  µm.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig1-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>MFN2 deficiency changes mice embryonic fibroblast (MEF) morphology.</title><p>(<bold>A</bold>) Immunofluorescence of F-actin (phalloidin), α-tubulin, and mitochondria (Mito Tracker) in <italic>wt</italic>, <italic>Mfn1</italic>-null, and <italic>Mfn2</italic>-null MEFs. (<bold>B–D</bold>) Cre-induced <italic>Mfn2</italic> disruption in MEFs from <italic>Mfn2</italic><sup>flox/flox</sup> mice displays similar cell morphology as <italic>Mfn2</italic>-null MEFs (<bold>B</bold>). (<bold>E, F</bold>) Cell spread area (<bold>E</bold>) and circularity (<bold>F</bold>) of indicated cells in <xref ref-type="fig" rid="fig2">Figure 2J</xref>. The individual points represent the circularity or spread area of individual MEF cells in (<bold>C–F</bold>). (<bold>G</bold>) Cells were transfected with mitochondria probes. <italic>Mfn2</italic>-null MEFs and <italic>Mfn2</italic>-null MEFs overexpressing MFN1 display large and fragmented mitochondria, while MFN2 re-expression in <italic>Mfn2</italic>-null MEFs restored mitochondria tubules. One representative result of three biological repeats is shown in (<bold>A, B</bold>). n = 25 cells in each group are quantified in (<bold>C–-F</bold>). ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA). Scale bars: 10 µm in (<bold>A, B</bold>), 20 µm in (<bold>G</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig1-figsupp1-v2.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video1.mp4" id="video1"><label>Video 1.</label><caption><title>MFN2 regulates the migration and spreading of mice embryonic fibroblasts (MEFs).</title><p>Cell spreading and random migration of <italic>wt</italic>, <italic>Mfn2</italic>-null, and <italic>Mfn1</italic>-null MEFs in the µ-slide 15 min after plating. Time-lapse images were taken every 10 min for 16 hr and 40 min. Individual MEFs were tracked for velocity quantification. Scale bar: 50 m.</p></caption></media><p>To further confirm the functional role of the MFN2 on cytoskeletal organization and cell migration, we re-expressed MFN1 or MFN2 in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Only MFN2 re-expression significantly increased cell motility (0.32 ± 0.18 µm/min), comparing to <italic>Mfn2</italic>-null MEFs (0.22 ± 0.18 µm/min), or those with MFN1 re-expression (0.21 ± 0.15 µm/min) (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>, <xref ref-type="video" rid="video2">Video 2</xref>). Notably, MFN2 re-expression also rescued the cell’s ability to polarize during the spreading process (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), increased cell area, and decreased circularity (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>). Similarly, doxycycline (DOX)-induced re-expression of MFN2 for 48 hr in <italic>Mfn2</italic>-null MEFs also significantly restored the actin cytoskeleton organization and cell morphology (<xref ref-type="fig" rid="fig2">Figure 2J</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E and F</xref>). Additionally, re-expressing MFN2, but not MFN1, in <italic>Mfn2</italic>-null MEFs restored the tubular mitochondrial network (<xref ref-type="fig" rid="fig1s1">Figure 1- figure supplements 1G</xref>). Together, these results suggest that these cells’ morphological reorganizations and migratory defects are specifically caused by the loss of MFN2 protein in MEFs.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Cre expression of MFN2 rescues random migration and spreading defects in Mfn2-null mice embryonic fibroblasts (MEFs).</title><p>(<bold>A</bold>) Western blot determining the expression level of MFN1 and MFN2 in indicated MEF cells. Percentages of knockdown or re-expression were calculated by normalizing the intensity to vinculin first, then normalizing to the wt group. (<bold>B–D</bold>) Representative images with individual tracks (<bold>B</bold>), quantification of velocity (<bold>C</bold>), and Wind–Rose plots (<bold>D</bold>) of indicated MEF cells during random migration. (<bold>E</bold>) Quantification of cell circularity of wt and Mfn2-null MEFs with vec, MFN1, or MFN2 re-expressed during spreading at indicated time points. Data are presented as mean ± SD in (<bold>E</bold>) (n = 5). (<bold>F, G</bold>) Cell circularity (<bold>F</bold>) and cell spreading area (<bold>G</bold>) of indicated MEFs measured after overnight culture. (<bold>H, I</bold>) Percentage of Actin abundance in the cell border region (<bold>H</bold>) and peripheral actin band (PAB) cell percentage in each view was quantified using our custom algorism (see <xref ref-type="fig" rid="fig2s1">Figure 2-figure supplement 1</xref>). (<bold>J</bold>) Representative images of wt, Mfn2-null with doxycycline-induced MEF2 (DIn-MFN2) MEF cells treated with or without doxycycline for 48 hr. The cells are immunostained with phalloidin and MFN2. One representative result of three biological repeats is shown in (<bold>A, B, D, H</bold>). Data are pooled from three independent experiments in (<bold>C, F–I</bold>). n = 30 cells are tracked and counted in (<bold>C</bold>); n = 35 cells are quantified in (<bold>F–H</bold>). Five different views from three biological repeats are quantified in (<bold>I</bold>). *p≤0.05, **p≤0.01, ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA in <bold>C, E, F</bold>, unpaired <italic>t</italic>-test in <bold>H, I</bold>). Scale bars: 50 µm in (<bold>B</bold>), 10 µm in (<bold>J</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig2-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Custom algorithm to identify cells with peripheral actin band (PAB).</title><p>(<bold>A</bold>) Representative images of <italic>wt</italic> and <italic>Mfn2</italic>-null mice embryonic fibroblasts (MEFs) stained with F-actin (phalloidin) under a 40× microscope. Scale bar: 50 µm. (<bold>B</bold>) FiloQuant plugin in ImageJ was used to identify cell edges and the actin cytoskeleton. The algorithm defines a 20-pixel stroke inside the cell border as the ‘border region’ and then calculates the percentage of the actin cytoskeleton in the border region and the cell circularity. If the circularity is higher than 0.6, and more than 50% of the actin cytoskeleton is in the border region, we consider the cell a PAB cell.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig2-figsupp1-v2.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video2.mp4" id="video2"><label>Video 2.</label><caption><title>MFN2 re-expression, but not MFN1, restores migratory defects in <italic>Mfn2</italic>-null mice embryonic fibroblasts (MEFs).</title><p>Cell spreading and random migration of <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs with <italic>vec</italic>, MFN1, or MFN2 re-expressed in the µ-slide. Time-lapse images were taken every 10 min for 14 hr and 50 min. Individual MEFs were tracked for velocity quantification. Scale bar: 50 m.</p></caption></media><p>The significant differences in actin architecture in <italic>Mfn2</italic>-null MEFs, an atypical PAB, could account for the spreading and migratory defects (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref> and <xref ref-type="fig" rid="fig2">Figure 2H</xref>). We used the ImageJ plugin FiloQuant (<xref ref-type="bibr" rid="bib43">Jacquemet et al., 2019</xref>) to quantify the cells with PAB structure. We developed an algorithm to calculate the percentage of actin in the cell border region (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>). If the cell’s border region contains more than 50% actin, and the cellular circularity is higher than 0.6, we consider it a ‘PAB’ cell. <italic>Mfn2</italic>-null MEFs displayed a significantly higher ‘PAB’ rate (33.2%), while MFN2 re-expression reduced the average ‘PAB’ rate to 16.3% (<xref ref-type="fig" rid="fig2">Figure 2H and I</xref>).</p></sec><sec id="s2-2"><title>Increased cytosolic Ca<sup>2+</sup> suppresses cell migration in <italic>Mfn2</italic>-null MEFs</title><p>These striking alternations in cell morphology, spreading, and migration prompted us to investigate the downstream effectors of MFN2. We focused on one of the MFN2-specific functions: maintaining cellular Ca<sup>2+</sup> homeostasis by tethering ER and mitochondria. It was previously reported that the increased distance between ER and mitochondria in the absence of MFN2 elevates cytosolic Ca<sup>2+</sup> transients in MEFs (<xref ref-type="bibr" rid="bib18">de Brito and Scorrano, 2008</xref>; <xref ref-type="bibr" rid="bib27">Filadi et al., 2015</xref>; <xref ref-type="bibr" rid="bib62">Naon et al., 2016</xref>). We, therefore, measured cytosol Ca<sup>2+</sup> in response to PDGF-BB stimulation and confirmed the previous observation (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). To evaluate the effect of cytosolic Ca<sup>2+</sup> accumulation on MEF cell migration, we treated <italic>wt</italic> MEFs with the calcium ionophore A23187, an ion carrier facilitating Ca<sup>2+</sup> transport across the plasma membrane. A23187 increased cytosol Ca<sup>2+</sup> levels in <italic>wt</italic> MEFs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). A reduction in cell migration speed was observed in a dose-dependent manner, which phenocopied the motility reduction in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The treatment of A23187 increased the percentage of actin in the cell border region. However, it failed to phenocopy the ‘PAB’ structure in <italic>wt</italic> MEFs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C–E</xref>), indicating that excessive cytosolic Ca<sup>2+</sup> is not sufficient to induce the ‘PAB’ structure.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>CMFN2 regulates random migration through cytosolic Ca<sup>2+</sup> and endoplasmic reticulum (ER)-mitochondria tether.</title><p>(<bold>A</bold>) Fluo-4 recordings of cytosolic Ca<sup>2+</sup> in the indicated cell lines after PDGF-BB stimulation. (<bold>B</bold>) Quantification of the velocity of <italic>wt</italic> mice embryonic fibroblast (MEF) random migration in the presence of vehicle or different concentrations of the Ca<sup>2+</sup> ionophore A23187. (<bold>C, D</bold>) Representative images with individual tracks (<bold>C</bold>) and quantification of velocity (<bold>D</bold>) of wt or Mfn2-null MEFs during random migration with or without the presence of the intracellular calcium chelator BAPTA-AM. (<bold>E</bold>) Western blot of GFP in indicated cell lines. Mfn2<sup>-/-</sup>+T, Mfn2-null MEFs with synthetic ER-GFP-mitochondria tether construct. (<bold>F, G</bold>) Representative images with individual tracks (<bold>F</bold>) and quantification of velocity (<bold>G</bold>) of indicated MEF cells. (<bold>H</bold>) Fluo-4 recordings of cytosolic Ca<sup>2+</sup> in the indicated cell lines after PDGF-BB stimulation. The individual points in (<bold>B, D, G</bold>) are the mean speeds for individual MEF cells. Data are presented as mean ± SD in (<bold>A, H</bold>). Data are pooled from three independent experiments in (<bold>A, H</bold>). One representative result of three biological repeats is shown in (<bold>C–G</bold>). n = 30 cells are tracked and counted in (<bold>B, G</bold>). n = 35 cells are tracked and measured in (<bold>D</bold>). ***p&lt;0.001, ****p&lt;0.0001 (one-way ANOVA in <bold>B, G</bold> and two-way ANOVA in <bold>D</bold>). Scale bars: 50 µm.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig3">Figure 3E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Excessive cytosolic Ca<sup>2+</sup> is insufficient to phenocopy the peripheral actin band (‘PAB’) structure in <italic>wt</italic> mice embryonic fibroblasts (MEFs), while the cytosolic Ca<sup>2+</sup> inhibitor BAPTA rescues ‘PAB’ structure in <italic>Mfn2</italic>-null MEFs.</title><p>(<bold>A, B</bold>) Fluo-4 recordings of cytosolic Ca<sup>2+</sup> in the indicated cell lines after PDGF-BB stimulation. (<bold>C</bold>) Immunofluorescence of F-actin (phalloidin) in wt MEFs treated with DMSO or A23187, and <italic>Mfn2</italic>-null MEFs treated with DMSO or BAPTA. (<bold>D, E</bold>) Percentage of actin abundance in the cell border region (<bold>D</bold>) and the percentage of PAB cells (<bold>E</bold>) identified by our custom algorism in indicated cell lines. Data are pooled from three independent experiments and presented as mean ± SD in (<bold>A, B</bold>). n = 28 cells are measured in (<bold>D</bold>). Five different views from two biological repeats are quantified in (<bold>E</bold>). *p≤0.1, ****p&lt;0.0001 (two-way ANOVA in <bold>D, E</bold>). Scale bars: 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Expression of MEF2 or an endoplasmic reticulum (ER)-mitochondria tether construct restores ER-mitochondria contacts and mitochondria morphology.</title><p>(<bold>A, B</bold>) Cells were co-transfected with the ER probe and SPLICS<sub>L</sub> Mt-ER long P2A probe. Representative images of SPLICS<sub>L</sub> probe (green) and ER (red) (<bold>A</bold>) and quantification (<bold>B</bold>) of SPLICS<sub>L</sub> contacts by 3D rendering of complete z-stacks. (<bold>C</bold>) Peripheral actin band (PAB) cell percentage was quantified using our custom algorithm in <italic>Mfn2</italic>-null mice embryonic fibroblasts (MEFs) with <italic>vec</italic> or ER-mito tethering construct. n = 7 cells from two independent experiments. Five different views from two biological repeats are quantified in (<bold>C</bold>). *p≤0.1, ***p≤0.001 (one-way ANOVA in <bold>B</bold>, Student’s <italic>t-</italic>test in <bold>C</bold>). Scale bars: 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig3-figsupp2-v2.tif"/></fig></fig-group><p>On the other hand, the ‘PAB’ structure was rescued by inhibiting cytosolic Ca<sup>2+</sup> in <italic>Mfn2</italic>-null MEFs with an intracellular calcium chelator BAPTA-AM (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–E</xref>, <xref ref-type="fig" rid="fig3">Figure 3C and D</xref>, <xref ref-type="video" rid="video3">Video 3</xref>). Consistently, the reduced motility in <italic>Mfn2</italic>-null MEFs was partially rescued, suggesting that the PAB structure and defects on migration described above in <italic>Mfn2</italic>-null MEFs can be explained, at least in part, by excessive cytosolic Ca<sup>2+</sup>.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Cytosolic Ca<sup>2+</sup> inhibition restores the migration defects in <italic>Mfn2</italic>-null mice embryonic fibroblast (MEF) cells.</title><p>Cell spreading and random migration of <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs treated with DMSO or BAPTA-AM (20 μM) in the μ-slide. Time-lapse images were taken every 10 min for 14 hr and 30 min. MEFs were tracked for velocity quantification. Scale bar: 50 μm.</p></caption></media><p>To confirm that MEF2 regulates cytosolic Ca<sup>2+</sup> via maintaining ER-mitochondria tether, we introduced an artificial tether construct (<xref ref-type="bibr" rid="bib52">Kornmann et al., 2009</xref>) into the <italic>Mfn2</italic>-null MEFs (<italic>Mfn2</italic><sup>-/-</sup>+T). The tether comprises a GFP protein carrying ER and mitochondrial localization sequences at opposite ends, which functions independently of MFN2. We adopted an established probe to detect the ER-mitochondria contacts (<xref ref-type="bibr" rid="bib95">Vallese et al., 2020</xref>). In line with previous studies, <italic>Mfn2</italic>-null MEFs displayed significantly decreased ER-mitochondria contacts and MFN1 re-expression failed to restore the phenotype. Expressing MFN2 or the artificial tether construct restored ER-mitochondria contacts in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A and B</xref>). Indeed, expressing the tether corrected the cytosolic Ca<sup>2+</sup> levels in response to PDGF-BB stimulation partially rescued the migration speed in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig3">Figure 3F–H</xref>, <xref ref-type="video" rid="video4">Video 4</xref>) and decreased PAB cell percentage (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). These data suggest that MFN2 regulates cell morphology and adhesive migration in MEFs by maintaining mitochondria-ER interaction and Ca<sup>2+</sup> homeostasis.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video4.mp4" id="video4"><label>Video 4.</label><caption><title>Restoring the endoplasmic reticulum (ER)-mitochondrial tether rescues the migration defects in <italic>Mfn2</italic>-null mice embryonic fibroblast (MEF) cells.</title><p>Cell spreading and random migration of <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs with <italic>vec</italic> or synthetic tether construct in the µ-slide. Time-lapse images were taken every 10 min for 17 hr and 50 min. Individual MEFs were tracked for velocity quantification. Scale bar: 50 m.</p></caption></media></sec><sec id="s2-3"><title>Elevated CaMKII activation is associated with MFN2-regulated random migration</title><p>Given that cytosolic Ca<sup>2+</sup> plays essential roles in MFN2-mediated cytoskeleton regulation and cell migration, we looked at the kinases and phosphatases regulated by Ca<sup>2+</sup>/ calmodulin (CaM), including CaMKK, CaMKII, and calcineurin, which are previously shown to regulate actin bundling (<xref ref-type="bibr" rid="bib80">Saneyoshi and Hayashi, 2012</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). AIP, the CaMKII inhibitor, partially restored motility in <italic>Mfn2</italic>-null MEFs. Neither the calcineurin inhibitor FK506 nor the CaMKK inhibitor STO609 had any effect (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>, <xref ref-type="video" rid="video5">Video 5</xref>). We found a higher level of phosphorylated or active CaMKII in <italic>Mfn2</italic>-null MEFs, which was also reduced by the expression of MFN2 or the tether (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). The function of CamKII was further confirmed by expressing a wild-type (CaMKII-WT) or a dominant negative (CaMKII-DN) version of CamKII in <italic>Mfn2</italic>-null MEFs. CaMKII-DN, but not CaMKII-WT, induced a moderate but significant increase in migration velocity (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>, <xref ref-type="video" rid="video6">Video 6</xref>). Together, our results indicate a role of CaMKII in cytoskeleton regulation in <italic>Mfn2</italic>-null MEFs.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>CaMKII activation mediates Mfn2 deficiency-induced inhibition in mice embryonic fibroblast (MEF) migration.</title><p>(<bold>A</bold>) Selected signaling cascades involved in the regulation of the actin cytoskeleton via Ca<sup>2+</sup>. Blue arrows indicate positive regulation. Dashed blue arrows indicate positive regulation with unclear mechanisms. Orange T-shaped bars indicate negative regulation of the pharmacological inhibitors. (<bold>B</bold>) Quantification of the velocity of indicated MEF cells treated with DMSO, the CaMKII inhibitor AIP, the Calcineurin inhibitor FK506, or the CaMKK inhibitor STO609. (<bold>C</bold>) Representative images with individual tracks of wt or Mfn2-null MEFs treated with the CaMKII inhibitor AIP. (<bold>D, E</bold>) Western blot (<bold>E</bold>) and quantification (<bold>F</bold>) determining the amount of pCaMKII and pan-CaMKII in wt, Mfn2-null MEFs with vec, CaMKII-WT, or CaMKII-DN overexpressed after treating with 25 µM PDGF-BB for 4 min. (<bold>F, G</bold>) Quantification of velocity (<bold>G</bold>) and representative images with individual tracks (<bold>F</bold>) of wt, Mfn2-null MEFs with vec, CaMKII-WT, or CaMKII-DN overexpressed during random migration. One representative result of three biological repeats is shown in (<bold>B, C, F, G</bold>). Four biological repeats are shown in (<bold>E</bold>). n = 40 cells are quantified in (<bold>B, G</bold>). *p≤0.05, ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA in <bold>E, G</bold> and two-way ANOVA in <bold>B</bold>). Scale bars: 50 µm.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig4-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig4-v2.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video5.mp4" id="video5"><label>Video 5.</label><caption><title>CaMKII inhibition rescues the migration defects in <italic>Mfn2</italic>-null mice embryonic fibroblast (MEF) cells.</title><p>Cell spreading and random migration of <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs treated with DMSO or AIP (40 μM) in the μ-slide. Time-lapse images were taken every 10 min for 17 hr and 50 min. MEFs were tracked for velocity quantification. Scale bar: 50 μm.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video6.mp4" id="video6"><label>Video 6.</label><caption><title>Expression of CaMKII-DN rescues the migration defects in <italic>Mfn2</italic>-null mice embryonic fibroblast (MEF) cells.</title><p>Cell spreading and random migration of <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs with <italic>vec</italic>, CaMKII-WT, or CaMKII-DN in the μ-slide. Time-lapse images were taken every 10 min for 17 hr and 50 min. MEFs were tracked for velocity quantification. Scale bar: 50 μm.</p></caption></media></sec><sec id="s2-4"><title>MFN2 deficiency-induced migration defect is independent of Rac and CDC42</title><p>The Rho GTPase family members are master regulators of the actin cytoskeleton and cell migration. The peripheral enrichment of actin filaments and extensive membrane ruffles we observed in <italic>Mfn2</italic>-null MEF cells resembled the classic phenotype seen in fibroblasts with constitutively active Rac (<xref ref-type="bibr" rid="bib35">Hall, 1998</xref>). Therefore, we hypothesized that Rac might be overactivated in MFN2-depleted MEF cells. We performed a RAC-GTP pulldown and observed no significant increase in the absence of MFN2 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A and B</xref>). In addition, the Rac inhibitor, CAS1090893, did not rescue the cell motility defect of the <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig5s1">Figure 5-figure supplement 1C</xref>), suggesting that Rac is not the primary effector regulated by MFN2. CDC42-GTP levels are comparable between the <italic>wt</italic> and <italic>Mfn2</italic>-null cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D and E</xref>).</p></sec><sec id="s2-5"><title>Loss of MFN2 drives overactivation of RhoA GTPase and redistribution of focal adhesions</title><p>In contrast to the minor changes in Rac and CDC42 activity, we detected a marked increase of RhoA-GTP in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Restoring MFN2 expression or introducing the ER-mitochondria artificial tether brought the RhoA activation level back to the <italic>wt</italic> level. We then compared the distribution of focal adhesion protein paxillin (Pax) by immunofluorescence. The focal adhesions were fewer and restricted to the cell periphery in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). In addition to the striking PAB architecture described previously, the focal adhesion complexes in <italic>Mfn2</italic>-null MEFs appeared larger, consistent with the observation of RhoA overactivation in fibroblasts (<xref ref-type="bibr" rid="bib35">Hall, 1998</xref>; <xref ref-type="fig" rid="fig5">Figure 5E</xref>). We plated the cells on fibronectin, fibrinogen, or uncoated cover glasses. We discovered that the PAB formation is independent of the extracellular substrates (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). These focal adhesion differences hinted that the spreading and migration defects in cells depleted of MFN2 might be explained, at least in part, by significantly increased RhoA activity. Moreover, BAPTA-AM treatment or DOX-induced MFN2-re-expression reduced the heightened activity of RhoA in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig5">Figure 5F and G</xref>), indicating that the cytosolic Ca<sup>2+</sup> increase was responsible for the RhoA overactivation in <italic>Mfn2</italic>-null MEFs.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of MFN2 induces heightened RhoA activation in mice embryonic fibroblasts (MEFs).</title><p>(<bold>A, B</bold>) RhoA pulldown activation assay demonstrates increased RhoA-GTP in <italic>Mfn2</italic>-null MEFs, which can be corrected by re-expressing MFN2 or inducing a mitochondria-endoplasmic reticulum (ER) tether. (<bold>A</bold>) Western blot and (<bold>B</bold>) quantification determining the amount of RhoA-GTP and total RhoA protein in <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs, <italic>Mfn2</italic>-null MEFs with MFN2 re-expression, or with an artificial ER-mitochondria tether; the indicated cell lines were treated with 25 ng/ml PDGF-BB for 0 or 4 min. (<bold>C</bold>) Immunofluorescence of F-actin (phalloidin) and Paxillin in <italic>wt</italic>, <italic>Mfn1</italic>-null, and <italic>Mfn2</italic>-null MEFs after overnight culture. (<bold>D, E</bold>) <italic>Mfn2</italic>-null MEFs display slightly decreased FA numbers (<bold>D</bold>) but significantly larger FA sizes (<bold>E</bold>). (<bold>F, G</bold>) RhoA pulldown activation assay demonstrates cytosolic Ca<sup>2+</sup> inhibition corrects RhoA-GTP level in <italic>Mfn2</italic>-null MEFs. (<bold>F</bold>) Western blot and (<bold>G</bold>) quantification showing the amount of RhoA-GTP protein in <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs, <italic>Mfn2</italic>-null MEFs treated with BAPTA, or <italic>Mfn2</italic>-null MEFs with doxycycline (DOX)-induced MFN2 re-expression for 48 hr; the indicated cells were treated with 25 ng/ml PDGF-BB for the indicated time. RhoA-GTP/total RhoA ratios at 4 min were normalized to 0 min to show the fold changes in (<bold>B, G</bold>). n = 30 cells were quantified in (<bold>D, E</bold>). One representative result of two biological repeats is shown in (<bold>A, B, F, G</bold>). *p≤0.05 (one-way ANOVA comparing each group with the average of the <italic>wt</italic> group). Scale bar: 50 µm.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig5-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig5-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Activities of Rac and Cdc42 are not increased in MFN2-deficient mice embryonic fibroblasts (MEFs).</title><p>(<bold>A</bold>) Western blot and (<bold>B</bold>) quantification of the amount of RAC-GTP and total RAC protein in wt, Mfn2-null MEFs, Mfn2-null MEFs with MFN2 re-expressed, or with an artificial endoplasmic reticulum (ER)-mitochondria tether. The indicated cell lines were treated with 25 ng/ml PDGF-BB for 0 or 4 min. (<bold>C</bold>) Quantification of the velocity of indicated MEF cells treated with DMSO or Rac inhibitor CAS1090893 (50 µM) overnight. (<bold>D, E</bold>) Cdc42 pulldown activation assay demonstrates no difference in Cdc42-GTP in wt and Mfn2-null MEFs. (<bold>D</bold>) Western blot and (<bold>E</bold>) quantification of the amount of CDC42-GTP and total CDC42 protein in wt, Mfn2-null MEFs treated with 25 ng/ml PDGF-BB 0 or 4 min. One representative result of three biological repeats is shown in (<bold>A, D</bold>). Data are pooled from three independent experiments in (<bold>B, C, E</bold>). n &gt; 25 cells were quantified in <bold>C</bold>. Error bars represent SD. NS, nonsignificant (two-way ANOVA in <bold>C</bold>, one-way ANOVA in <bold>B</bold>, unpaired <italic>t</italic>-test in <bold>E</bold>).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig5-figsupp1-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig5s1sdata2"><label>Figure 5—figure supplement 1—source data 2.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig5-figsupp1-data2-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig5-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Increased myosin regulatory light chain activity is critical for PAB formation in <italic>Mfn2</italic>-null MEFs</title><p>To fully understand the downstream mechanism of MFN2 in regulating the cytoskeleton, we used pharmacological inhibitors for proteins regulated by CaM (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B and C</xref>, <xref ref-type="video" rid="video7">Video 7</xref>). The RhoA inhibitor I, the Rho-associated protein kinase (ROCK) inhibitor Y27632, the myosin inhibitor Blebbistatin, and the myosin light chain kinase (MLCK) inhibitor ML-7 showed the most pronounced effects on restoring both the motility and cell morphology in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B and C</xref>, <xref ref-type="video" rid="video5">Video 5</xref>). The focal adhesion kinase inhibitor 14 (FAK inhibitor 14), the LIM kinase (LIMK) inhibitor BMS-5, and the Arp2/3 inhibitor CK-666 had no statistically significant effects on restoring cell motility (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). This result was confirmed by analyzing the actin filament organization and focal adhesion distribution in inhibitor-treated <italic>Mfn2</italic>-null MEFs. RhoA inhibitor-I, ML-7, Y27632, or Blebbistatin abrogated the PAB in <italic>Mfn2</italic>-null MEFs and restored typical fibroblast characteristics, including the formation of filopodia, developed cell edges, and focal adhesions at the leading and trailing edges (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Taken together, these findings demonstrate a potential mechanism whereby excessive cytosolic Ca<sup>2+</sup> in the absence of MFN2 leads to the overactivation of RhoA and MLCK, which increases MLC activity and contributes to the PAB in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Small-molecule inhibitors targeting RhoA- and MLCK-related signaling pathways rescue MFN2 deficiency-induced phenotypes.</title><p>(<bold>A, B</bold>) Cellular spread area (<bold>A</bold>) and circularity (<bold>B</bold>) of <italic>wt</italic> and <italic>Mfn2</italic>-null mice embryonic fibroblasts (MEFs) treated with indicated inhibitors overnight. (<bold>C</bold>) Immunofluorescence of F-actin (phalloidin) and Paxillin in <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs treated with indicated inhibitors overnight. (<bold>D</bold>) Schematic of the effectors and their inhibitors (red) in MFN2-regulated signaling network leading to Actin bundle. Increased cytosolic Ca<sup>2+</sup> may activate MLCK, CaMKII, and RhoA-ROCK, which activate MLC and affect actin bundle formation. One representative result of three biological repeats is shown in (<bold>C</bold>). Data are pooled from three independent experiments, and n = 30 cells are quantified in (<bold>A, B</bold>). *p≤0.05, **p≤0.01, ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA comparing each group to the average of <italic>Mfn2<sup>-/-</sup></italic> DMSO group). Scale bars: 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>RhoA and MLC drive peripheral actin band (‘PAB’) structure in MFN2-deficient mice embryonic fibroblasts (MEFs).</title><p>(<bold>A</bold>) Immunofluorescence of F-actin (phalloidin) and Paxillin in <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs cultured on uncoated, collagen-coated, or fibrinogen-coated cover glasses. (<bold>B</bold>) Velocity quantification of indicated MEF cells treated with DMSO, the Rho inhibitor-I, the MLCK inhibitor ML-7, the ROCK inhibitor Y27632, the myosin inhibitor Blebbistatin, FAK inhibitor-14, the LIM kinase inhibitor BMS-5, or the Arp2/3 inhibitor CK666. (<bold>C</bold>) Representative images with individual tracks of indicated MEF cells treated with DMSO or indicated inhibitors. (<bold>D</bold>) A small-molecular inhibitor screen revealed the schematic of the effectors and their inhibitors (red) in the MFN2-regulated signaling network leading to the Actin bundle. Data are pooled from three independent experiments in (<bold>B</bold>) and n&gt;30 cells are quantified. ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA comparing each group to the average of <italic>Mfn2<sup>-/-</sup></italic> DMSO group). Scale bars: 50 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig6-figsupp1-v2.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-88828-video7.mp4" id="video7"><label>Video 7.</label><caption><title>Small-molecule inhibitors targeting RhoA and MLCK downstream signaling pathways rescue the migration defects in <italic>Mfn2</italic>-null mice embryonic fibroblast (MEF) cells.</title><p>Cell spreading and random migration of <italic>wt</italic> treated with DMSO and <italic>Mfn2</italic>-null MEFs treated with DMSO, RhoA inhibitor-I (0.1 µg/ml), ML-7 (2 µM), Y29632 (5 µM), or Blebbistatin (4 µM) in the μ-slide. Time-lapse images were taken every 10 min for 14 hr and 30 min. MEFs were tracked for velocity quantification. Scale bar: 50 μm.</p></caption></media><p>Given the essential role of the MLC, we probed for pMLCII in <italic>wt</italic>, <italic>Mfn1</italic>-null, and <italic>Mfn2</italic>-null MEFs. As expected, the pMLCII level was significantly increased in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>), which could be corrected by expressing MFN2 or the artificial tether in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig7">Figure 7C and D</xref>). Using immunofluorescence microscopy, we noted that pMLCII colocalized with peripheral actin bundles in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). To confirm the importance of MLC activity, we knocked down the two MLC kinases, MLCK or ROCK, in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Both knockdown cell lines displayed significantly reduced pMLCII levels (<xref ref-type="fig" rid="fig7">Figure 7G</xref>), restored stress fiber architecture, and redistributed focal adhesions (<xref ref-type="fig" rid="fig7">Figure 7H</xref>). Both knockdown lines also showed significantly decreased PAB cell percentages with increases in cell spread area and more polarized morphology (<xref ref-type="fig" rid="fig7">Figure 7I–L</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Heightened MLC activity promotes the peripheral actin band (‘PAB’) structure in MFN2-deficient mice embryonic fibroblasts (MEFs).</title><p>(<bold>A, B</bold>) Western blot (<bold>A</bold>) and quantification (<bold>B</bold>) of the amount of pMLCII and total MLCII in <italic>wt</italic>, <italic>Mfn1</italic>-null, and <italic>Mfn2</italic>-null MEFs. (<bold>C, D</bold>) Increased pMLCII in <italic>Mfn2</italic>-null MEFs can be corrected by re-expressing MFN2 or inducing a mitochondria-endoplasmic reticulum (ER) tether. (<bold>C</bold>) Western blot and (<bold>D</bold>) quantification determining the amount of pMLCII and total MLCII protein in <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs, <italic>Mfn2</italic>-null MEFs with MFN2 re-expressed, or with an artificial ER-mitochondria tether. (<bold>E</bold>) Representative images of <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs immunostained for F-actin (phalloidin), pMLCII, and DAPI. (<bold>F</bold>) Western blot determining the expression levels of MLCK or ROCK in <italic>Mfn2</italic>-null MEFs with <italic>shMLCK</italic> or <italic>shROCK</italic>. (<bold>G</bold>) Western blot of pMLCII and total MLCII <italic>Mfn2</italic>-null MEFs with <italic>shMLCK</italic> or <italic>shROCK</italic>. (<bold>H</bold>) Representative images of <italic>Mfn2</italic>-null MEFs with <italic>shMLCK</italic> or <italic>shROCK</italic> immunostained for F-actin (green) and paxillin (red). (<bold>I, J</bold>) Cellular spread area and circularity of <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs with <italic>vec, shMLCK,</italic> or <italic>shROCK</italic> were measured after overnight culture. (<bold>K</bold>) Percentage of actin abundance in the cell border region in <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs, <italic>Mfn2</italic>-null MEFs with <italic>shMLCK</italic> or <italic>shROCK</italic>. (<bold>L</bold>) Percentage of PAB cells identified by a custom algorithm in <italic>wt</italic>, <italic>Mfn2</italic>-null MEFs, <italic>Mfn2</italic>-null MEFs with <italic>shMLCK</italic> or <italic>shROCK</italic>. The individual points stand for the size or circularity of individual MEF cells. One representative result of three biological repeats is shown in (<bold>A, B, F, G</bold>). Four biological repeats were done in (<bold>C, D</bold>). Data are pooled from three independent experiments in (<bold>I, J</bold>). n = 30 cells are quantified in (<bold>I, K</bold>). Five different views from three biological repeats are quantified in (<bold>L</bold>). *p≤0.05, **p≤0.01, ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA, comparing each group to the average of <italic>Mfn2<sup>-/-</sup> vec</italic> group in <bold>I, K</bold>). Scale bars: 20 µm in (<bold>H</bold>), 10 µm in (<bold>E</bold>).</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig7-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig7">Figure 7C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig7-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig7">Figure 7F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig7-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata4"><label>Figure 7—source data 4.</label><caption><title>Original blots and figures with the bands labeled for <xref ref-type="fig" rid="fig7">Figure 7G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-88828-fig7-data4-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>The cell lines with restored motility show different oxygen consumption rates.</title><p>(<bold>A, C, E</bold>) Representative graph showing oxygen consumption rate (OCR) of indicated mice embryonic fibroblast (MEF) cells. (<bold>B, D, F</bold>) Basal respiration, ATP-linked respiration, maximal respiratory, and spare capacity of indicated cell lines. One representative result of three biological repeats in (<bold>A–F</bold>). Error bars represent SD. *p≤0.05, **p≤0.01, ***p≤0.001, ****p&lt;0.0001 (two-way ANOVA).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig7-figsupp1-v2.tif"/></fig></fig-group><p>As MFN2 is a mitochondrial protein, we also performed a seahorse assay to measure mitochondrial functions in each cell line. <italic>Mfn2</italic>-null MEFs showed a decreased rate of oxidative phosphorylation relative to <italic>wt</italic> and <italic>Mfn1</italic>-null MEFs (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A and B</xref>), while MFN2 re-expression or introducing ER-mitochondrial tether increased the overall oxygen consumption rate in <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C and D</xref>). Knocking down MLCK in <italic>Mfn2</italic>-null MEFs enhanced oxidative metabolism, whereas ROCK knockdown reduced oxygen consumption (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E and F</xref>). Given that MLCK and ROCK knockdown can restore cell spreading and migration in <italic>Mfn2</italic>-null MEFs, alterations in mitochondrial metabolism are unlikely to be the primary determinant in PAB formation.</p></sec><sec id="s2-7"><title>Myosin regulatory light chain overexpression phenocopied MFN2 depletion</title><p>Mitochondria and MFN2 regulate multiple cellular signaling pathways in addition to cytosolic calcium. To determine whether the PAB is primarily driven by RhoA or MLCK activation, we attempted to constitute the PAB in <italic>wt</italic> MEFs. We first tried Rho activator treatment or expression of constitutively active MLCK (MLCK-CA) (<xref ref-type="bibr" rid="bib101">Wong et al., 2015</xref>; <xref ref-type="fig" rid="fig8">Figure 8A</xref>). <italic>Wt</italic> MEFs treated with Rho activator exhibited more and thicker bundles of actin filaments, with mesh-like structure, across the dorsal side of the cells, but maintained their overall polarized morphology. This observation is consistent with the known function of RhoA to induce central stress fiber formation in fibroblasts (<xref ref-type="bibr" rid="bib48">Katoh et al., 2001a</xref>; <xref ref-type="bibr" rid="bib49">Katoh et al., 2001b</xref>). In contrast, MLCK-CA expression increased peripheral stress fibers and noticeably fewer bundles of actin filaments in the central portion but maintained the classic polarized morphology. When combined (Rho activator treatment + MLCK-CA expression), the effect was increased, with the cells’ thick actin bundles along the periphery. These cells, however, retained their protrusive structures and polarized shape (<xref ref-type="fig" rid="fig8">Figure 8A, D, and E</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>MRLC overexpression and Rho activation in <italic>wt</italic> mice embryonic fibroblasts (MEFs) recapitulates the peripheral actin band (‘PAB’) structure.</title><p>(<bold>A</bold>) Immunofluorescence of F-actin (phalloidin) in <italic>wt</italic> MEFs with or Rho activator treatment or introducing MLCK-CA expression. (<bold>B</bold>) Representative images of <italic>wt</italic> MEFs expressing MRLC-GFP with or without the Rho Activator, immunostained for F-actin (phalloidin). (<bold>C, D</bold>) Spread area and circularity of <italic>wt</italic> MEFs with the indicated overexpression or drug treatment. The individual points stand for the size or circularity of individual MEF cells. (<bold>E, F</bold>) Percentage of actin abundance in the cell border region (<bold>E</bold>) and the percentage of PAB cells (<bold>F</bold>) identified by our custom algorism in indicated cell lines. One representative result of three biological repeats is shown in (<bold>A, B</bold>). Data are pooled from three independent experiments in (<bold>C–E</bold>). n = 30 cells are tracked and counted in (<bold>C–E</bold>). Four different views from three biological repeats are quantified in (<bold>F</bold>). *p≤0.05, **p≤0.01, ***p≤0.001, ****p&lt;0.0001 (one-way ANOVA, comparing each column with the mean of the <italic>wt</italic> group). Scale bars: 10 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig8-v2.tif"/></fig><p>To our surprise, when we attempted to image the myosin dynamics in <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs, we noticed a large percentage of <italic>wt</italic> MEFs with round shapes and peripherally enriched actin filaments after overexpressing the GFP-tagged myosin regulatory light chain (MRLC-GFP) (<xref ref-type="fig" rid="fig8">Figure 8B and E</xref>). Cells expressing MRLC-GFP were significantly smaller and became round (<xref ref-type="fig" rid="fig8">Figure 8C and D</xref>). However, they still preserved their filopodia and other cell protrusions. When these cells were treated with the Rho activator, a noticeable percentage (24%) displayed the PAB morphology, including a decrease in cell area and an increase in cell roundness (<xref ref-type="fig" rid="fig8">Figure 8B–F</xref>). In summary, the combination of MRLC overexpression with pharmacological activation of RhoA is sufficient to drive PAB formation in MEFs.</p></sec><sec id="s2-8"><title>Loss of MFN2 displays different cytoskeletal architecture with increased cell contractile forces</title><p>To better virtualize the individual actin filaments in the PAB, we performed 3D super-resolution imaging of F-actin in <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). <italic>Wt</italic> MEF displays interconnected actin network including peripheral actin fibers (blue box) parallel to the cell membrane and branched actin filaments pointing to cell protrusions against membrane (green box). However, in <italic>Mfn2</italic>-null MEFs, thick actin bundles are present parallel to the cell membrane (blue box) with a region of disordered meshwork attached to the membrane (green box). Overall, stress fibers at the cell center are largely missing in <italic>Mfn2</italic>-null MEFs. We then used atomic force microscopy (AFM) to measure cell stiffness. <italic>Mfn2</italic>-null MEFs showed a softer Young’s modulus than <italic>wt</italic> cells (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1A–C</xref>), consistent with the previous report that cells with apical stress fibers are stiffer than cells without (<xref ref-type="bibr" rid="bib24">Efremov et al., 2019</xref>). We then measured plasma membrane tension using the Flipper-TR dye and FLIM imaging (<xref ref-type="bibr" rid="bib17">Colom et al., 2018</xref>). Upon addition of the hyperosmotic sucrose solution, Flipper-TR lifetime dropped significantly in MEFs, confirming that a longer probe lifetime corresponds to a membrane environment under higher tension (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1D and E</xref>). Consistently, <italic>Mfn2</italic>-null MEFs showed a lower fluorescence lifetime, indicating lower membrane tension than the <italic>wt</italic> (<xref ref-type="fig" rid="fig9s1">Figure 9-figure supplement 1F and G</xref>). The reduced membrane stiffness and tension are consistent with a less spread cell morphology.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Mfn2-null mice embryonic fibroblasts (MEFs) exhibit altered actin organization and cell stiffness.</title><p>(<bold>A</bold>) 3D super-resolution reconstructions of immunofluorescence-labeled F-actin in wt or Mfn2-null MEFs. x–y overview of a 1.7-µm-thick volume of the cells. (<bold>B</bold>) Morphology of indicated MEF cells on polyacrylamide (PAA) substrates after overnight culture immunostained with Alexa-488 phalloidin. A traction stress map with color values corresponding to different stress values is shown on the right. Scale bars: 50 μm. Quantification of the corresponding cell spreading areas (<bold>C</bold>), total strain energy (<bold>D</bold>), and total strain energy normalized to cell area (<bold>E</bold>). (<bold>F</bold>) Representative images of indicated MEF cells on polyacrylamide (PAA) substrates of different stiffness after overnight culture. The cells are immunostained with Alexa-488 phalloidin. (<bold>G</bold>) The cell circularity of the indicated cells is measured. The individual points stand for the circularity of individual MEF cells. One representative result of three biological repeats is shown in (<bold>C, F</bold>). Data are pooled from three independent experiments in (<bold>C–E, G</bold>). n &gt; 40 cells are counted in (<bold>B–E</bold>). *p≤0.05, ****p&lt;0.0001 (unpaired <italic>t</italic>-test). Scale bars: 2 µm in (<bold>A</bold>), 50 µm in (<bold>B</bold>), and 10 µm in (<bold>F</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title><italic>Mfn2</italic>-null mice embryonic fibroblasts (MEFs) exhibit altered cell stiffness and membrane tension.</title><p>(<bold>A</bold>) Schematic of the cantilever probe indenting cells at cell center during atomic force microscopy (AFM) process. (<bold>B</bold>) Measurement of effective cell modulus (mean ± SEM) of <italic>wt</italic> or <italic>Mfn2</italic>-null MEFs (n ≥ 15 for each group). (<bold>C</bold>) Representative AFM force curves of the cantilever probe <italic>wt</italic> or <italic>Mfn2</italic>-null MEFs. (<bold>D</bold>) Representative FLIM images and (<bold>E</bold>) quantification of the Flipper-TR probe’s lifetime on wt MEFs under regular and hypertonic conditions. (<bold>F</bold>) Representative FLIM images and (<bold>G</bold>) quantification of the Flipper-TR probe’s lifetime on <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs. One representative result of three biological repeats in (<bold>A, D, F</bold>). Data are pooled from three independent experiments in (<bold>B</bold>). Error bars represent SD. **p≤0.01, ****p&lt;0.0001 (unpaired <italic>t</italic>-test in<bold> B, E, G</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-88828-fig9-figsupp1-v2.tif"/></fig></fig-group><p>The prominent peripheral F-actin bundled with MLC (<xref ref-type="fig" rid="fig7">Figure 7E</xref>) possibly generates a nonpolar, global contraction at the cell periphery. We, therefore, utilized traction force microscopy (TFM) to measure the contractile force of the <italic>Mfn2</italic>-null MEFs (<xref ref-type="bibr" rid="bib65">Oakes et al., 2014</xref>). After normalizing to the cell area, the average strain energy in <italic>Mfn2</italic>-null MEFs is significantly higher than with <italic>wt</italic> cells, which correlated with the elevated actin-myosin level. Since fibroblasts generate more traction force on stiffer substrates (<xref ref-type="bibr" rid="bib58">Lo et al., 2000</xref>), we then asked whether or to which extent substrate stiffness affects the PAB structure in <italic>Mfn2</italic>-null MEFs. We cultured the cells on polyacrylamide (PAA) gels with different stiffness and stained F-actin (<xref ref-type="fig" rid="fig9">Figure 9F</xref>). As previously reported, <italic>wt</italic> cells showed diminished cell spreading and rounder morphology on softer substrates. In contrast, <italic>Mfn2</italic>-null MEFs displayed a more elongated cell shape on softer substrates, with partially restored stress fibers at the cell center (<xref ref-type="fig" rid="fig9">Figure 9F and G</xref>). These results suggest that substrate stiffness affects cell spreading, and strong substrate interaction or outside-in signal is required for the ‘PAB’ structure in <italic>Mfn2</italic>-null MEFs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our results show that loss of MFN2 protein results in defective spreading and polarization, along with reduced motility of MEF cells in 2D migration. This phenotype results from an increased cytosolic Ca<sup>2+</sup> level upon Mfn2 removal and loss of ER-mitochondria tethers, which lead to the higher activity of calcium-regulated kinases, including CaMKII and MLCK, overactive RhoA and NMII, and an accumulation of peripherally localized actin and myosin, which we named the ‘PAB.’ The cell morphology of <italic>Mfn2</italic>-null MEFs can be rescued by restoring MFN2 expression, introducing ER-mitochondria artificial tethers, or inhibiting cytosolic Ca<sup>2+</sup>, CaMKII, MLCK, RhoA, or MRLC. Thus, together, these data identify the mechanism for how Mfn2 regulates cell spreading and adhesive migration in MEFs and highlight its essential function in maintaining mitochondria-ER contact and regulating the actomyosin network.</p><p>In line with the ‘PAB’ structure and markedly enriched myosin at the cell periphery in <italic>Mfn2</italic>-null MEFs, they displayed higher strain energy as determined by TFM. The findings suggest that increased peripheral traction force hampered <italic>Mfn2</italic>-null MEFs from further spreading. However, the MFN2 KO cells have increased actomyosin contractility only at the cell–substrate interface but not throughout the entire cell cortex. A less spread cell would have a more relaxed membrane and display a lower membrane tension, consistent with our observation in FLIM imaging of Flipper-TR dye. Softer matrices reduce cell contractility at the cell–substrate interface, which allows MFN2 KO cells to relax and spread better, given that a certain percentage of <italic>Mfn2</italic>-null MEFs gained elongated morphology on soft substrates. It is well known that mechanical forces play a significant role in regulating cell adhesion and cytoskeletal organization (<xref ref-type="bibr" rid="bib22">Discher et al., 2005</xref>; <xref ref-type="bibr" rid="bib9">Burridge and Chrzanowska-Wodnicka, 1996</xref>). Cells generate higher traction stresses on stiffer substrates, and contractility-induced tension drives the formation of stress fibers and focal adhesions. Conversely, stress fibers and focal adhesions disassemble when contractility is inhibited (<xref ref-type="bibr" rid="bib9">Burridge and Chrzanowska-Wodnicka, 1996</xref>; <xref ref-type="bibr" rid="bib73">Pelham and Wang, 1997</xref>; <xref ref-type="bibr" rid="bib101">Wong et al., 2015</xref>). A possible explanation of our observation is that the ‘outside-in’ feedback loop coupling with the elasticity of the extracellular microenvironment abrogated the aberrant ‘PAB’ architecture.</p><p>Cell migration is a highly dynamic process in which actin treadmilling and focal adhesion turnover orchestrate front-to-rear polarity and cell movements. Rac is known for its regulatory functions in the formation of focal complexes and lamellipodia at the front (<xref ref-type="bibr" rid="bib36">Hall, 2005</xref>; <xref ref-type="bibr" rid="bib64">Nobes and Hall, 1999</xref>; <xref ref-type="bibr" rid="bib63">Nobes and Hall, 1995</xref>), while RhoA modulates actomyosin contraction (<xref ref-type="bibr" rid="bib76">Ridley and Hall, 1992</xref>) and focal adhesion disassembly (<xref ref-type="bibr" rid="bib76">Ridley and Hall, 1992</xref>; <xref ref-type="bibr" rid="bib64">Nobes and Hall, 1999</xref>; <xref ref-type="bibr" rid="bib63">Nobes and Hall, 1995</xref>) at the rear end. Our previous research proved that MFN2 suppresses Rac activation and supports neutrophil cell adhesion (<xref ref-type="bibr" rid="bib108">Zhou et al., 2020</xref>). However, we found that RhoA, instead of Rac, dominates actin cytoskeleton reorganization in <italic>Mfn2</italic>-null MEFs. This difference is not entirely surprising, given that these two cells utilize different migratory modes. Neutrophils are a type of fast amoeboid-migrating cell that do not form mature focal adhesions during cell migration, even on specific substrates (<xref ref-type="bibr" rid="bib54">Lämmermann et al., 2008</xref>; <xref ref-type="bibr" rid="bib19">De Bruyn, 1946</xref>). In contrast, slower-moving cells, like fibroblasts, form mature focal adhesions and require focal adhesion recycling to move (<xref ref-type="bibr" rid="bib55">Lauffenburger and Horwitz, 1996</xref>; <xref ref-type="bibr" rid="bib82">Seetharaman and Etienne-Manneville, 2020</xref>). Despite described controversies concerning the dominant downstream effectors in neutrophils and fibroblasts, the proposed negative regulatory function of MFN2 on cytosolic Ca<sup>2+</sup> levels and its functional role in cell migration was consistent in both cell lines.</p><p>The elevation of cytosolic Ca<sup>2+</sup> concentration is known to induce the activation of MLCK. MLCK phosphorylates the 20 kDa regulatory MLC at S19 and consequently activates the myosin ATPase activity (<xref ref-type="bibr" rid="bib41">Ikebe and Hartshorne, 1985</xref>). The Rho-kinase, ROCK, also controls MLC activity by phosphorylating at Ser19 and Thr 18 (<xref ref-type="bibr" rid="bib47">Kassianidou et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Totsukawa et al., 2000</xref>). It is reported that the biphosphorylated MLC (pp-MLC) localizes to the cell center. In contrast, the monophosphorylated MLC (p-MLC) tends to be located in the cell periphery (<xref ref-type="bibr" rid="bib47">Kassianidou et al., 2017</xref>). Indeed, this is consistent with our observation that the pp-MLC level did not change when we probed pp-MLC with an antibody specific for both Ser19 and Thr18 (data not shown). Only MLC pSer19 was markedly elevated in <italic>Mfn2</italic>-null MEFs. However, interestingly, either MLCK inhibitor ML-7 or ROCK inhibitor Y27632 restored cell morphology and motility in MEFs without MFN2. Our data suggested that both ROCK and MLCK are required for enhanced MLC phosphorylation at Ser19 in the MFN2-null MEFs.</p><p>The RhoA/ROCK signaling pathway is essential in response to cytosolic Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib94">Uehata et al., 1997</xref>; <xref ref-type="bibr" rid="bib80">Saneyoshi and Hayashi, 2012</xref>; <xref ref-type="bibr" rid="bib105">Ying et al., 2009</xref>). PDZ-RhoGEF is a vital effector in response to cytosolic Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib105">Ying et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Derewenda et al., 2004</xref>). Cytosolic Ca<sup>2+</sup> activates RhoA through the PYK2/PDZ-RhoGEF pathway in five cell lines (Primary rat aortic vascular smooth muscle cells, HEK293T, MDCK, Neuron2A, and PC12) (<xref ref-type="bibr" rid="bib105">Ying et al., 2009</xref>). In line with the previous observation (<xref ref-type="bibr" rid="bib105">Ying et al., 2009</xref>), BAPTA-AM abolishes RhoA activation in our current work. Further work will be required to determine whether PDZ-RhoGEF or other molecules mediate Rho activation with heightened intracellular Ca<sup>2+</sup> levels in fibroblasts.</p><p>Besides the effectors we identified here, focal adhesion proteins, including focal adhesion kinase (FAK) and proteins of the FAK–Src signaling complex, are also known as crucial modulators participating in interactions with the extracellular matrix and the cytoskeleton (<xref ref-type="bibr" rid="bib71">Parsons et al., 2010</xref>; <xref ref-type="bibr" rid="bib32">Giannone et al., 2007</xref>; <xref ref-type="bibr" rid="bib31">Gardel et al., 2010</xref>; <xref ref-type="bibr" rid="bib61">Mitra et al., 2005</xref>). Intracellular forces generated by focal adhesion proteins promote rear retraction and the forward movement of the cell. The dynamic turnover of focal adhesions is spatiotemporally controlled by intracellular Ca<sup>2+</sup> signaling (<xref ref-type="bibr" rid="bib59">Machacek et al., 2009</xref>; <xref ref-type="bibr" rid="bib61">Mitra et al., 2005</xref>). In addition, calpains allow the degradation of FAPs, including FAK and Talin, in a Ca<sup>2+</sup>-dependent manner (<xref ref-type="bibr" rid="bib50">Kerstein et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Goll et al., 2003</xref>). Based on the extensive peripheral focal adhesions we observed in <italic>Mfn2</italic>-null MEFs, calpains or other focal adhesion proteins may also contribute to the ‘PAB’ structure.</p><p>Neonates are susceptible to MFN2 defects (<xref ref-type="bibr" rid="bib28">Filadi et al., 2018</xref>), and over 100 dominant mutations in the MFN2 gene have been reported in Charcot–Marie–Tooth disease type 2A (CMT2A) patients. However, how these mutations lead to disease is largely unknown, and there is currently no cure for this disease (<xref ref-type="bibr" rid="bib96">Verhoeven et al., 2006</xref>; <xref ref-type="bibr" rid="bib11">Calvo et al., 2009</xref>). MFN2 mutations are also associated with many other conditions, such as Alzheimer’s disease, Parkinson’s disease, obesity, and diabetes (<xref ref-type="bibr" rid="bib51">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib100">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Bach et al., 2003</xref>). One of the challenges in MFN2 research is that MFN2 plays multiple functional roles in cell signalings, such as regulating mitochondrial dynamics, transport, mtDNA stability, lipid metabolism, and cell survival. Both gain-of-function and loss-of-function mutations are reported in CMT2A patients. Some MFN2 mutations lead to fusion‐incompetent mitochondria. However, some are fusion‐competent mutations (<xref ref-type="bibr" rid="bib84">Strickland et al., 2014</xref>; <xref ref-type="bibr" rid="bib13">Cartoni et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">El Fissi et al., 2018</xref>; <xref ref-type="bibr" rid="bib30">Franco et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Rocha et al., 2018</xref>). It is also worth noting that MFN2 dysfunction preferentially impacts peripheral nerves instead of central nerves. These phenotypes are generally attributed to deficient mitochondrial trafficking and localization to the dendrites (<xref ref-type="bibr" rid="bib70">Pareyson et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">Baloh et al., 2007</xref>). Our observations may provide a potential novel explanation of how MFN2 deficiency affects cell physiology by modulating the mechanosensitivity and cytoskeletal organization of the cells. It is possible that the MFN2 disease mutations also disrupt the mitochondria-ER tether and result in defects in cell cytoskeleton architecture, cell spreading, and migration, which cause the progression of the diseases. It is also possible that the same MFN2 mutation induces distinct signaling alterations in different cell types or diseases.</p><p>In summary, we characterized the alteration of the cytoskeleton and biophysical properties in MFN2-deficient cells and identified the detailed molecular mechanism. Our work provides insights into how MFN2 deficiency affects cell morphology and motility, specifically via the actin cytoskeleton.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Cell culture</title><p>HEK293T (CRL-11268), wild-type (CRL-2991), <italic>Mfn2</italic>-null (CRL-2993), and <italic>Mfn1</italic>-null (CRL-2992) MEFs were from the American Type Culture Collection (ATCC, Manassas, VA). GP2-293 cells were purchased from Takara Bio USA (#631458). All cells were maintained at 37°C with 5% CO<sub>2</sub> in a Forma Steri-Cycle i160 CO2 Incubator (NC1207547, Thermo Fisher Scientific). Cells were cultured in 10% FBS in DMEM with sodium bicarbonate. Cell lines were authenticated using STR profiling. Mycoplasma contamination was absent in monthly tests using Mycoplasma Detection PCR. To obtain MFN2 re-expression cell line, introduce the ER-mito tethering structure, or express CaMKII-WT, CaMKII-DN, MLCK-CA, or MRLC-GFP, the MSCV-puro vector (Takara Bio USA, #634401) were used. We cloned the gene of interest into the MSCV vector and cotransfected the vector plasmid along with the envelope plasmid pVSVG, at a ratio of 1:1, into GP2-293 cells using Lipofectamine 3000 (Invitrogen L3000015). Virus supernatant was collected at 48 hpt and 72 hpt and further concentrated with Lenti-X concentrator (Clontech 631232). MEF cells were transduced with concentrated retrovirus in a complete medium and then selected with 2 µg/ml puromycin (Gibco A1113803) starting the next day. The stable lines were generated after puromycin selection for 1 wk. To generate ROCK or MLCK knocking down lines in <italic>Mfn2-null</italic> MEF cells, pLKO.1 lentiviral constructs with shRNAs were obtained from Sigma-Aldrich (shROCK: TRCN0000022903, shMLCK: TRCN0000024037), and SHC 003 was used as a non-targeting control. The plasmid of lentiviral constructs together with pCMV-dR8.2 dvpr (Addgene #8455) and pCMV-VSV-G (Addgene #8454), at a ratio of 10:7.5:2.5, were cotransfected into HEK293T cells with Lipofectamine 3000 (Invitrogen L3000015) to produce lentivirus. Virus supernatant was collected at both 48 hpt and 72 hpt, and further concentrated with Lenti-X concentrator (Clontech 631232) before transduction. 2 µg/ml puromycin (Gibco A1113803) was added into the complete medium on the next day for selection.</p></sec><sec id="s4-2"><title>Plasmids</title><p>In-Fusion cloning (In-Fusion HD Cloning Plus Kit, Clontech) was used to fuse the fragments with the linearized backbone. MSCV-puro was digested by Xho I and EcoR I. pLIX_403 plasmid was digested by NsiI and BamHI. The plasmids of Mfn1-Myc and Mfn2-Myc were gifts from David Chan (Addgene plasmid # 23212, #23213). The mito-GFP-ER plasmid was from the plasmid used in our lab (Addgene plasmid #160509). pLIX_403 was a gift from David Root (Addgene plasmid # 41395). GFP-C1-CAMKIIalpha and GFP-C1-CAMKIIalpha-K42R were gifts from Tobias Meyer (Addgene #21226, #21221). pTK91_GFP-MRLC2 was also from Addgene (Addgene #46355). The lentiviral backbone pLIX_403 was a gift from David Root (Addgene plasmid # 41395). pSLIK CA MLCK was a gift from Sanjay Kumar (Addgene plasmid # 84647). pYFP-paxillin was a gift from Kenneth Yamada (Addgene #50543). SPLICS Mt-ER Long P2A and pCytERM_mScarlet_N1 were gifts from Dorus Gadella (Addgene plasmid #164107 and # 85066).</p><p>The In-Fusion primers are listed below:</p><list list-type="simple"><list-item><p>MSCV-mfn2 insert F: <named-content content-type="sequence">CACGATAATACCATGGGCCACCATGTCCCTGCTC</named-content></p></list-item><list-item><p>MSCV-mfn2 insert R: <named-content content-type="sequence">TCTAGAGTCGCGGCCGCTTACTTGTACAGCTCGTCCATGCC</named-content></p></list-item><list-item><p>MSCV-mfn1 insert R: <named-content content-type="sequence">TCGACTCTAGAGTCGCGGCCGCTTACTTGTACAGCTCGTCCATGCC</named-content></p></list-item><list-item><p>Mfn2 into plix-Nsil-F: <named-content content-type="sequence">AAAACCCCGGTCCTATGCATATGTCCCTGCTCTTCTCTCGA</named-content></p></list-item><list-item><p>Mfn2 into plix-BamHI-R: <named-content content-type="sequence">CCCCAACCCCGGATCCTTATCTGCTGGGCTGCAGGT</named-content></p></list-item><list-item><p>Camk2a-MSCV-F: <named-content content-type="sequence">AATTAGATCTCTCGAGGCCACCATGGTGAGCAAGG</named-content></p></list-item><list-item><p>Camk2a-MSCV-R: <named-content content-type="sequence">CTACCCGGTAGAATTCATTCGGCGAAGCAAGAGCG</named-content></p></list-item><list-item><p>ER-mito F: <named-content content-type="sequence">AATTAGATCTCTCGAGATGGCAATCCAGTTGCGTTCG</named-content></p></list-item><list-item><p>ER-mito R: <named-content content-type="sequence">ATTTACGTAGCGGCCGCTTAAGATACATTGATGAGTTTGG</named-content></p></list-item><list-item><p>MRLC-GFP F: <named-content content-type="sequence">AATTAGATCTCTCGAGGCCACCATGGTGAGCAAGG</named-content></p></list-item><list-item><p>MRLC-GFP R: <named-content content-type="sequence">CTACCCGGTAGAATTCGCCCGCGGTCAGTCATCTTTG</named-content></p></list-item><list-item><p>MLCK-CA F: <named-content content-type="sequence">attagatctctcgagactagtcgactggatcc</named-content></p></list-item><list-item><p>MLCK-CA R: <named-content content-type="sequence">ccggtagaattcagatcttgggtgggttaattaa</named-content></p></list-item></list></sec><sec id="s4-3"><title>Chemicals</title><p>MEF cells were treated with 1% DMSO, 20 µM BAPTA (Cayman Chemical), Y27632 5 µM (Cayman Chemical), 50 µM CK666 (Cayman Chemical), STO-609 acetate (Biotechne, #1551), A23187 (Cayman Chemical), 4 µM Blebbistatin (Cayman Chemical), 40 uM AIP (R&amp;D Systems #5959/1), 50 µM CAS 1090893 (Millipore, #553511), 0.1 µg/ml RhoA inhibitor-I (Cytoskeleton, Inc, #CT-04), 2 µM FK-506 (Cayman Chemical, # 10007965), 300 nM FAK14 (Cayman Chemical, #14485), 10 µM BMS-5 (Cayman Chemical, #21072), or 2 µM ML-7 (Cayman Chemical, #11801) overnight during time-lapse imaging for random cell migration or followed by immunostaining.</p></sec><sec id="s4-4"><title>Western blot</title><p>Total protein was isolated from cells using RIPA buffer containing 25 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS). For samples containing phosphor proteins to probe, 20 mM sodium fluoride (NaF), 1 mM sodium orthovanadate (Na<sub>2</sub>VO<sub>3</sub>), 10 mM beta glycerophosphate were added to the RIPA lysis buffer. Protein concentrations were determined using the Precision Red Advanced Protein Assay Reagent (Cytoskeleton ADV02). Extracted proteins (25–35 µg) were separated by 8–12% SDS-PAGE and transferred onto polyvinylidene difluoride membranes (PVDF, Bio-Rad). Membranes were blocked for ~30 min in PBST (PBS and 0.1% Tween 20) with 5% fat-free milk. After blocking, membranes were incubated with primary antibodies diluted 1:1000 in 1% BSA at 4°C overnight and secondary antibodies diluted 1:10,000 in PBST at room temperature for 1 hr. Odyssey (LI-Cor) was used to image membranes. Immunodetection of the pulldown samples was performed using enhanced Western Blotting Chemiluminescence Luminol Reagent (Santa Cruz Biotechnology, Cat# sc-2048) and detected with a FluorChem R System (Proteinsimple). Image Studio 5.0 was used to quantify and analyze the results. Primary antibodies anti-Mfn2 (Cell Signaling 9482S), anti-Mfn1 (Abcam, ab126575), anti-pan-CaMKII (Cell Signaling #3362), anti-phosphor-CaMKII (Thr286) (Cell Signaling #12716), anti-phospho myosin light chain 2 (Cell Signaling #3671), anti-myosin light chain 2 (Cell Signaling #3672), anti-phospho-PAK (Cell Signaling #2605S), anti-PAK (Cell Signaling #2604), and secondary antibody HRP AffiniPure goat anti-rabbit IgG (Jackson ImmunoResearch, #111-035-003), goat anti-mouse IgG Alexa Fluor 680 (Invitrogen, #A28183), and goat anti-rabbit IgG Alexa Fluor Plus 800 (Invitrogen, #A32735).</p></sec><sec id="s4-5"><title>Rac-GTP and RhoA-GTP pulldown assay</title><p>PAK-GST-coated beads (Cytoskeleton BK035) and Rhotekin-RBD-coated beads (Cytoskeleton BK036) were used to isolate active Rac and RhoA from the whole-cell lysate. MEF cells were serum starved with DMEM medium lacking FBS overnight in the incubator at 70–80% confluency. After starvation, PDGF-BB was then added to the cells at a final concentration of 25 µM. Then, cells were lysed with ice-cold lysis buffer at indicated time points and collected by scrapples. Then, 15 µg PAK-GST beads or 50 µg Rhotekin-RBD-coated beads were mixed with each sample and incubated at 4°C for 1 hr. Protein beads were washed and processed for western blot.</p></sec><sec id="s4-6"><title>Immunostaining and confocal imaging</title><p>For immunofluorescent staining, MEF cells with or without drug treated overnight were plated onto coverslips and incubated overnight at 37°C, then fixed with 4% paraformaldehyde (PFA) solution in PBS for 15 min at room temperature. Cells were permeabilized in PBS with 0.1% Triton X-100 and 3% fatty acid-free BSA for 1 hr, then incubated with phalloidin Alexa Fluor 488 (Invitrogen A12379) or primary antibodies diluted 1:100 in 3% BSA overnight at 4°C. After washing with PBS three times, the cells were stained with secondary antibodies diluted 1:500 in 3% BSA and DAPI (Invitrogen D3571) for 1 hr at room temperature. After washing with PBS three times, the coverslips were mounted on glass slides with the mounting medium (Vector Laboratories H-1000). Primary antibodies anti-Mfn2 (Cell Signaling 9482S), anti-paxillin (Invitrogen AHO0492), and anti-phospho myosin light chain 2 (Cell Signaling 3671), and secondary antibodies anti-rabbit Alexa Fluor 488 (Invitrogen A-21441) and anti-mouse Alexa Fluor 568 (Invitrogen A-11004) were used. Images of F-actin and focal adhesions were acquired using an N-STORM/N-SIM TIRF microscope (Nikon) with a 1.49/60× Apo TIRF oil objective. For focal adhesion quantification, the built-in ‘threshold’ plugin in ImageJ was first used to isolate the focal adhesions in the images. Then the ‘analysize particles’ plugin was used to quantify the numbers and size. Images of F-actin with MFN2 or pMLCII were acquired by a laser-scanning confocal microscope (LSM 800, Zeiss) with a 1.4/63× oil immersion objective lens. Images were processed and analyzed with ImageJ. To quantify the cell area and circularity, phalloidin-stained cells were imaged with a 40× objective. Images were imported into ImageJ, FiloQuant plugin was used to identify cell edges and cytoskeleton, and ‘Particle Analysis’ was then used to calculate the cell area and circularity. A custom algorithm was developed to identify cells with PAB structure. The algorithm calculates the percentage of cytoskeleton intensity in the cell border region based on the output of the images by the FiloQuant plugin (available on <ext-link ext-link-type="uri" xlink:href="https://github.com/tomato990/CellEdgeAreaPercent">GitHub</ext-link>, copy archived at <xref ref-type="bibr" rid="bib90">Tomato990, 2023</xref>). SPLICS-L probe was used as described (<xref ref-type="bibr" rid="bib95">Vallese et al., 2020</xref>), and the images of ER-mitochondrial contacts were acquired with a Nikon Ti2 Inverted Microscope with Yokogawa W1 and SoRa Module, 63× objective was used here. A 3D reconstruction of the resulting image was obtained using the Volume J plugin (available <ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/plugins/volume-viewer.html">here</ext-link>). A selected face of the 3D rendering was then thresholded and used to count ER–mitochondria contact sites. Data were plotted in Prism 6.0 (GraphPad).</p></sec><sec id="s4-7"><title>2D migration live imaging</title><p>MEF cells were first trypsinized and replated onto fibrinogen-coated µ-slide 8-well plates (ibidi 80826) at a density of ~10,000 cells per well with a complete medium. Time-lapse images were acquired using BioTek Lionheart FX Automated Microscope with 20× phase lens at 10 min intervals of ~18 hr at 37°C with 5% CO<sub>2</sub>. The velocity of MEFs was measured using ImageJ with the MTrackJ plugin and plotted in Prism 6.0 (GraphPad). The rose plots and directionality index were generated or calculated by the Chemotaxis and Migration Tool 2.0.</p></sec><sec id="s4-8"><title>Ca<sup>2+</sup> measurement</title><p>Fluo-4 Calcium Imaging Kit (Invitrogen F10489) was used for cytosolic Ca<sup>2+</sup> measurement in MEFs. MEF cells were incubated with PowerLoad solution and Fluo-4 dye at 37°C for 15 min and then at room temperature for 15 min. After incubation, cells were washed with PBS one time. Time-lapse green fluorescence images were obtained with AXIO Zoom V16 microscope (Zeiss) at 1 min intervals of 25 min. Then, 50 µl of 2 mM PDGF-BB (Sigma, #P4056) was added to cells right after the first image was taken. The fold change of the fluorescence intensity was normalized to that of the first image. The fluorescence intensity was measured using ImageJ and plotted in Prism 6.0 (GraphPad).</p></sec><sec id="s4-9"><title>3D super-resolution imaging</title><p>Single-molecule super-resolution imaging was performed on a custom-built setup on an Olympus IX-73 microscope stand (Olympus America, IX-73) equipped with a 100×/1.35-NA silicone-oil-immersion objective lens (Olympus America, UPLSAPO100XS) and a PIFOC objective positioner (Physik Instrumente, ND72Z2LAQ). Samples were excited by a 642 nm laser (MPB Communications, 2RU-VFL-P-2000-642-B1R), which passed through an acoustic-optic tunable filter (AA Opto-electronic, AOTFnC-400.650-TN) for power modulation. The excitation light was focused on the pupil plane of the objective lens after passing through a filter cube holding a quadband dichroic mirror (Chroma, ZT405/488/561/647rpc). The fluorescent signal was magnified by relay lenses arranged in a 4f alignment to a final magnification of ~54 and then split with a 50/50 non-polarizing beam splitter (Thorlabs, BS016). Two mirrors delivered the split fluorescent signals onto a 90° specialty mirror (Edmund Optics, 47-005), axially separated by 590 nm in the sample plane, and then projected on an sCMOS camera (Hamamatsu, Orca-Flash4.0v3) with an effective pixel size of 119 nm. A bandpass filter (Semrock, FF01-731/137-25) was placed before detection. The imaging system was controlled by custom-written LabVIEW (National Instruments) programs.</p><p>Before imaging, the coverslip with cells on top was placed on a custom-made holder. Then, 100 μl of imaging buffer (10% [w/v] glucose in 50 mM Tris, 50 mM NaCl, 10 mM β-mercaptoethylamine hydrochloride [M6500, Sigma-Aldrich], 50 mM 2-mercaptoethanol [M3148, Sigma-Aldrich], 2 mM cyclooctatetraene [138924, Sigma-Aldrich], 2.5 mM protocatechuic acid [37580, Sigma-Aldrich], and 50 nM protocatechuate 3,4-dioxygenase [P8279, Sigma-Aldrich], pH 8.0) were added on top of the coverslip. Then another coverslip was placed on top of the imaging buffer. This coverslip sandwich was then sealed with two-component silicon dental glue (Dental-Produktions und Vertriebs GmbH, picodent twinsil speed 22).</p><p>Following the previous procedure (<xref ref-type="bibr" rid="bib104">Xu et al., 2020</xref>), the sample was first excited with the 642 nm laser at a low intensity of ~50 W/cm<sup>2</sup> to find a region of interest. Before fluorescence imaging, bright-field images of this region were recorded over an axial range from –1 to +1 μm with a step size of 100 nm as reference images for focus stabilization. Single-molecule blinking data were then collected at a laser intensity of 2–6 kW/cm<sup>2</sup> and a frame rate of 50 Hz. Imaging was conducted for ∼30 cycles with 2000 frames per cycle. Single-molecule localization was performed as described previously (<xref ref-type="bibr" rid="bib104">Xu et al., 2020</xref>).</p></sec><sec id="s4-10"><title>Seahorse mitochondrial respiration analysis</title><p>Mitochondrial respiration was measured with Seahorse XFe24 Analyzer (Agilent Technologies) according to the manual of Seahorse XF Cell Mito Stress Test Kit (Agilent Technologies, Cat# 103015-100). Briefly, MEF cells were plated on the XF24 cell culture microplate at a density of 50,000 cells per well. The seahorse sensor cartridge was hydrated with calibrant in a non-CO<sub>2</sub> incubator at 37°C overnight 1 d before measurement. On the day of measurements, cells were washed once and incubated in Seahorse XF base medium (pH 7.4, Agilent Technologies, Cat# 103334-100) supplemented with 1 mM sodium pyruvate, 2 mM glutamine, and 5.5 mM glucose. Cells were equilibrated at 37°C in a non-CO<sub>2</sub> incubator for 1 hr. The oxygen consumption rate was monitored at the basal state and after sequential injection of the mitochondrial compounds oligomycin (1 μg/ml), FCCP (1 μM), and Rotenone/antimycin A (both 1 μM) to induce mitochondrial stress. All mitochondrial respiration rates were generated and automatically calculated by the Seahorse Wave software with normalization to the cellular protein contents. Cellular protein contents were determined by the sulforhodamine B (SRB) assay as described (<xref ref-type="bibr" rid="bib98">Vichai and Kirtikara, 2006</xref>).</p></sec><sec id="s4-11"><title>Traction force microscopy and analysis</title><p>TFM was performed as described previously (<xref ref-type="bibr" rid="bib38">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="bib79">Sala and Oakes, 2021</xref>; <xref ref-type="bibr" rid="bib3">Aratyn-Schaus et al., 2010</xref>). Briefly, 22 × 30 mm #1.5 glass coverslips were activated by incubating with a 2% solution of 3-aminopropyltrimethyoxysilane (313255000, Acros Organics) diluted in isopropanol, followed by fixation in 1% glutaraldehyde (16360, Electron Microscopy Sciences) in ddH<sub>2</sub>0. Polyacrylamide gels (shear modulus: 16 kPa – final concentrations of 12% acrylamide [1610140, Bio-Rad] and 0.15% bis-acrylamide [1610142, Bio-Rad]) were embedded with 0.04 µm fluorescent microspheres (F8789, Invitrogen) and ~6 mg/ml acryloyl-X, SE (6-((acryloyl)amino)hexanoic acid)-labeled fibronectin (A20770, Thermo Fisher Scientific; FC010, EMD Millipore), and polymerized on activated glass coverslips for 1 hr at room temperature. After polymerization, gels were rehydrated for 1 hr in deionized H<sub>2</sub>O before seeding 1.0 × 10<sup>5</sup> cells on each gel in a 60 mm cell culture-treated Petri dish. Cells were allowed to spread overnight, and the next day SPY555-actin dye (SC202, Spirochrome) was added ~60 min before imaging. Images were taken of both the cells and underlying fluorescent beads. Following imaging, cells were removed from the gel by adding 0.025% SDS, and a reference image of the fluorescent beads in the unstrained gel was taken.</p><p>Analysis of traction forces was performed using code written in Python according to previously described approaches (<xref ref-type="bibr" rid="bib78">Sabass et al., 2008</xref>). Prior to processing, the reference bead image was aligned to the bead image with the cell attached. Displacements in the beads were calculated using an optical flow algorithm in OpenCV (Open Source Computer Vision Library, available on <ext-link ext-link-type="uri" xlink:href="https://github.com/opencv/opencv">GitHub</ext-link>) (<xref ref-type="bibr" rid="bib69">OpenCV contributors, 2022</xref>; <xref ref-type="bibr" rid="bib8">Bradski and Kaehler, 2008</xref>) with a window size of 16 pixels. Traction stresses were calculated using the FTTC approach (<xref ref-type="bibr" rid="bib10">Butler et al., 2002</xref>; <xref ref-type="bibr" rid="bib38">Huang et al., 2019</xref>) as previously described, with a regularization parameter of 9.34 × 10<sup>–9</sup>. The strain energy was calculated by summing one-half the product of the strain and traction vectors in the region under the cell (<xref ref-type="bibr" rid="bib65">Oakes et al., 2014</xref>) and normalized by the cell area as measured using the SPY555-actin image of the cell. Cells with residual energy of ≥20% were excluded from the data set. N = 4 with ≥9 cells per biological repeat.</p></sec><sec id="s4-12"><title>Substrate stiffness assay</title><p>Polyacrylamide gels with uniform stiffness were prepared as previously described (<xref ref-type="bibr" rid="bib25">Efremov et al., 2022</xref>). Briefly, 50 mm glass-bottom dishes (WPI, USA) were activated with 0.1 M NaOH, 4% (v/v) APTES ((3-aminopropyl)triethoxysilane, Sigma-Aldrich, USA) and 1% (v/v) glutaraldehyde (Sigma-Aldrich) in 1× PBS. To prepare a gel with a specific stiffness, different concentrations of acrylamide (40%, Sigma-Aldrich) and bis-acrylamide (1%, Sigma-Aldrich) were mixed with PBS 1× and 0.5% (w/v) Irgacure 2959 (0.5% w/v, (2-hydroxy-4′-(2-hydroxyethoxy))-2-methylpropiophenone, Sigma-Aldrich). Later, the gel solution was incubated at 37°C overnight and degassed for 30 min at room temperature. Next, to prepare one gel, 120 ul of the gel solution was poured into the center of an activated glass bottom dish and covered with 22 * 22 mm coverglass previously chloro-silanated with DCDMS (dichlorodimethylsilane, Sigma-Aldrich). Then, the dish was placed in a UV transilluminator for 10 min. Final concentrations of acrylamide (4%) and bis-acrylamide (0.2%, w/v) were chosen to prepare PAA gels with 1.67, 4.47, 10.61, 16.7, and 19.66 kPa Young’s modulus. The ratio is shown below:</p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Elastic modulus (kPa)</th><th align="left" valign="bottom">Acrylamide (ml) from <bold>40%</bold> stoch solution</th><th align="left" valign="bottom">bis-Acrylamide (ml) from <bold>2%</bold> stock solution</th><th align="left" valign="bottom">PBS <bold>1</bold>× (ml)</th></tr></thead><tbody><tr><td align="char" char="." valign="bottom">1.67</td><td align="char" char="." valign="bottom">0.075</td><td align="char" char="." valign="bottom">0.1125</td><td align="char" char="." valign="bottom">0.8125</td></tr><tr><td align="char" char="." valign="bottom">4.47</td><td align="char" char="." valign="bottom">0.125</td><td align="char" char="." valign="bottom">0.075</td><td align="char" char="." valign="bottom">0.8</td></tr><tr><td align="char" char="." valign="bottom">10.61</td><td align="char" char="." valign="bottom">0.250</td><td align="char" char="." valign="bottom">0.050</td><td align="char" char="." valign="bottom">0.7</td></tr><tr><td align="char" char="." valign="bottom">16.7</td><td align="char" char="." valign="bottom">0.250</td><td align="char" char="." valign="bottom">0.075</td><td align="char" char="." valign="bottom">0.675</td></tr><tr><td align="char" char="." valign="bottom">19.66</td><td align="char" char="." valign="bottom">0.2</td><td align="char" char="." valign="bottom">0.132</td><td align="char" char="." valign="bottom">0.668</td></tr></tbody></table></table-wrap></sec><sec id="s4-13"><title>Atomic force microscopy</title><p>An Asylum Research MFP3d Bio AFM system (Santa Barbara, CA) was used to measure the effective modulus of <italic>wt</italic> and <italic>Mfn2</italic>-null MEFs seeded in 60 mm polystyrene Petri dishes. A Nanoandmore CP-qp-SCONT-SiO-B-5 colloidal probe cantilever (Watsonville, CA) with a 3.5 µm probe diameter and 0.01 N/m nominal stiffness was used for these experiments. The optical lever sensitivity of the cantilever was calibrated using a static force–displacement curve, performed on the part of the polystyrene Petri dish not covered by the cells. The cantilever stiffness was determined to be 0.00664 N/m using the thermal tuning method in the air (<xref ref-type="bibr" rid="bib40">Hutter and Bechhoefer, 1993</xref>). AFM indentation experiments were performed using cells in phosphate-buffered saline (PBS) solution in a 6 cm Petri dish maintained at a constant temperature of 37°C using a Petri dish heater. For imaging, a sufficient amount of PBS was used to maintain cell viability, and a 100 µl drop of PBS was placed on the AFM cantilever tip to avoid the formation of air bubbles between the cantilever holder and the sample. Force–displacement curves were acquired for each cell by indenting them at the central region of the cell, close to the nucleus. The force spectroscopy experiments were performed for a single force cycle by setting trigger points on the cantilever deflection (u) and tip velocity. A time gap of &gt;45 s was incorporated between the indentation experiments within the same cell to account for stress relaxation. The force–displacement curve corresponding to the approach of the cantilever tip toward the substrate for each location was considered to quantify the effective cell modulus using the material properties of the cantilever and Hertzian contact mechanics model for a spherical indenting a flat plane (<xref ref-type="bibr" rid="bib37">Hertz, 1881</xref>; <xref ref-type="bibr" rid="bib34">Guo and Akhremitchev, 2006</xref>) According to this model, the force measured during cell indentation (F) is related to the cantilever indentation, δ, as (<xref ref-type="bibr" rid="bib44">Johnson, 1985</xref>)<disp-formula id="equ1"><mml:math id="m1"><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>4</mml:mn><mml:mi>E</mml:mi><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mrow></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:mn>3</mml:mn><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac><mml:msup><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:math></disp-formula></p><p>where µ is the Poisson’s ratio, E is the effective cell modulus, and R<sub>tip</sub> is the radius of the spherical cantilever tip. The cell is assumed to be incompressible with µ = 0.5. The force curves were delineated into a region prior to the contact point of the cantilever tip with the cell and the region after contact. Force data post-contact with the cell was used to calculate the effective cell modulus.</p></sec><sec id="s4-14"><title>FLIM imaging</title><p>Cells were placed in the incubator at 37°C in a humidified atmosphere containing 5% CO<sub>2</sub> for 20 min before imaging. For hyper-osmotic shock, MEF cells were treated with an 87 mM sucrose working solution in complete DMEM culture media devoid of phenol red and imaged after 15 min. Frequency-domain fluorescence lifetime imaging microscopy (FLIM) measurements were performed using a Nikon TE2000 confocal microscope with a 60×/1.2NA water immersion objective equipped with an Alba FastFLIM system (<xref ref-type="bibr" rid="bib86">Sun et al., 2011</xref>). Specifically, cells stained with Flipper-TR (Cytoskeleton, CY-SC020) were excited using a 488 nm pulsed laser with a modulation frequency of 20 MHz and imaged through a 595/40 nm bandpass filter followed by MPD APD detectors. After image collection, bi-exponential fitting of FLIM images was performed using VistaVision software (ISS) to obtain fluorescent lifetimes (τ<sub>1</sub> and τ<sub>2</sub>) of each pixel. Only the longest lifetime component (τ<sub>1</sub>) was used to represent relative membrane tension as described previously (<xref ref-type="bibr" rid="bib17">Colom et al., 2018</xref>).</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>Statistical analysis was performed with Prism 6 (GraphPad). An unpaired two-tailed Student’s <italic>t-</italic>test or one-way ANOVA was used to determine the statistical significance of differences between groups. A p-value&lt;0.05 was considered statistically significant.</p><p>Individual p-values are indicated in the figures, with no data points excluded from statistical analysis. One representative experiment of at leastthree independent repeats is shown.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Data curation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con8"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Data curation, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con12"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con13"><p>Data curation, Supervision</p></fn><fn fn-type="con" id="con14"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con15"><p>Supervision, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con16"><p>Supervision, Investigation, Methodology</p></fn><fn fn-type="con" id="con17"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con18"><p>Supervision, Methodology</p></fn><fn fn-type="con" id="con19"><p>Supervision, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con20"><p>Conceptualization, Supervision, Funding acquisition, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-88828-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1-5, 7 and Figure 5-figure Supplement 1.</p></sec><ack id="ack"><title>Acknowledgements</title><p>The work was supported by the National Institutes of Health (R35GM119787 to QD), (R35GM119785 to FH), (R01GM132501 to DU), and (P30CA023168 to Purdue Center for Cancer Research) for shared resources. This work is based upon efforts supported by EMBRIO Institute, contract #2120200, a National Science Foundation (NSF) Biology Integration Institute (to DC). YW is supported by Bisland Fellowship, Purdue University.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Cuenca</surname><given-names>R</given-names></name><name><surname>Juanes-García</surname><given-names>A</given-names></name><name><surname>Vicente-Manzanares</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Myosin II in mechanotransduction: master and commander of cell migration, morphogenesis, and cancer</article-title><source>Cellular and Molecular Life Sciences</source><volume>71</volume><fpage>479</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1007/s00018-013-1439-5</pub-id><pub-id pub-id-type="pmid">23934154</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>20246</fpage><lpage>20249</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.34.20246</pub-id><pub-id pub-id-type="pmid">8702756</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aratyn-Schaus</surname><given-names>Y</given-names></name><name><surname>Oakes</surname><given-names>PW</given-names></name><name><surname>Stricker</surname><given-names>J</given-names></name><name><surname>Winter</surname><given-names>SP</given-names></name><name><surname>Gardel</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Preparation of complaint matrices for quantifying cellular contraction</article-title><source>Journal of Visualized Experiments</source><volume>46</volume><elocation-id>2173</elocation-id><pub-id pub-id-type="doi">10.3791/2173</pub-id><pub-id pub-id-type="pmid">21178972</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>D</given-names></name><name><surname>Pich</surname><given-names>S</given-names></name><name><surname>Soriano</surname><given-names>FX</given-names></name><name><surname>Vega</surname><given-names>N</given-names></name><name><surname>Baumgartner</surname><given-names>B</given-names></name><name><surname>Oriola</surname><given-names>J</given-names></name><name><surname>Daugaard</surname><given-names>JR</given-names></name><name><surname>Lloberas</surname><given-names>J</given-names></name><name><surname>Camps</surname><given-names>M</given-names></name><name><surname>Zierath</surname><given-names>JR</given-names></name><name><surname>Rabasa-Lhoret</surname><given-names>R</given-names></name><name><surname>Wallberg-Henriksson</surname><given-names>H</given-names></name><name><surname>Laville</surname><given-names>M</given-names></name><name><surname>Palacín</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>H</given-names></name><name><surname>Rivera</surname><given-names>F</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Zorzano</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>17190</fpage><lpage>17197</lpage><pub-id pub-id-type="doi">10.1074/jbc.M212754200</pub-id><pub-id pub-id-type="pmid">12598526</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baloh</surname><given-names>RH</given-names></name><name><surname>Schmidt</surname><given-names>RE</given-names></name><name><surname>Pestronk</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>422</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4798-06.2007</pub-id><pub-id pub-id-type="pmid">17215403</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Báthori</surname><given-names>G</given-names></name><name><surname>Csordás</surname><given-names>G</given-names></name><name><surname>Garcia-Perez</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>E</given-names></name><name><surname>Hajnóczky</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ca2+-dependent control of the permeability properties of the mitochondrial outer membrane and voltage-dependent anion-selective channel (VDAC)</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>17347</fpage><lpage>17358</lpage><pub-id pub-id-type="doi">10.1074/jbc.M600906200</pub-id><pub-id pub-id-type="pmid">16597621</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>J</given-names></name><name><surname>Weeds</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Calcium and the cytoskeleton</article-title><source>British Medical Bulletin</source><volume>42</volume><fpage>385</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a072156</pub-id><pub-id pub-id-type="pmid">3307997</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bradski</surname><given-names>G</given-names></name><name><surname>Kaehler</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><source>Learning OpenCV: Computer Vision with the OpenCV Library</source><publisher-name>O’Reilly Media, Inc</publisher-name></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burridge</surname><given-names>K</given-names></name><name><surname>Chrzanowska-Wodnicka</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Focal adhesions, contractility, and signaling</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>12</volume><fpage>463</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.12.1.463</pub-id><pub-id pub-id-type="pmid">8970735</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>JP</given-names></name><name><surname>Tolić-Nørrelykke</surname><given-names>IM</given-names></name><name><surname>Fabry</surname><given-names>B</given-names></name><name><surname>Fredberg</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Traction fields, moments, and strain energy that cells exert on their surroundings</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>282</volume><fpage>C595</fpage><lpage>C605</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00270.2001</pub-id><pub-id pub-id-type="pmid">11832345</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>J</given-names></name><name><surname>Funalot</surname><given-names>B</given-names></name><name><surname>Ouvrier</surname><given-names>RA</given-names></name><name><surname>Lazaro</surname><given-names>L</given-names></name><name><surname>Toutain</surname><given-names>A</given-names></name><name><surname>De Mas</surname><given-names>P</given-names></name><name><surname>Bouche</surname><given-names>P</given-names></name><name><surname>Gilbert-Dussardier</surname><given-names>B</given-names></name><name><surname>Arne-Bes</surname><given-names>M-C</given-names></name><name><surname>Carrière</surname><given-names>J-P</given-names></name><name><surname>Journel</surname><given-names>H</given-names></name><name><surname>Minot-Myhie</surname><given-names>M-C</given-names></name><name><surname>Guillou</surname><given-names>C</given-names></name><name><surname>Ghorab</surname><given-names>K</given-names></name><name><surname>Magy</surname><given-names>L</given-names></name><name><surname>Sturtz</surname><given-names>F</given-names></name><name><surname>Vallat</surname><given-names>J-M</given-names></name><name><surname>Magdelaine</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations</article-title><source>Archives of Neurology</source><volume>66</volume><fpage>1511</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2009.284</pub-id><pub-id pub-id-type="pmid">20008656</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campello</surname><given-names>S</given-names></name><name><surname>Lacalle</surname><given-names>RA</given-names></name><name><surname>Bettella</surname><given-names>M</given-names></name><name><surname>Mañes</surname><given-names>S</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name><name><surname>Viola</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Orchestration of lymphocyte chemotaxis by mitochondrial dynamics</article-title><source>The Journal of Experimental Medicine</source><volume>203</volume><fpage>2879</fpage><lpage>2886</lpage><pub-id pub-id-type="doi">10.1084/jem.20061877</pub-id><pub-id pub-id-type="pmid">17145957</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartoni</surname><given-names>R</given-names></name><name><surname>Arnaud</surname><given-names>E</given-names></name><name><surname>Médard</surname><given-names>JJ</given-names></name><name><surname>Poirot</surname><given-names>O</given-names></name><name><surname>Courvoisier</surname><given-names>DS</given-names></name><name><surname>Chrast</surname><given-names>R</given-names></name><name><surname>Martinou</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A</article-title><source>Brain</source><volume>133</volume><fpage>1460</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1093/brain/awq082</pub-id><pub-id pub-id-type="pmid">20418531</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Detmer</surname><given-names>SA</given-names></name><name><surname>Ewald</surname><given-names>AJ</given-names></name><name><surname>Griffin</surname><given-names>EE</given-names></name><name><surname>Fraser</surname><given-names>SE</given-names></name><name><surname>Chan</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development</article-title><source>The Journal of Cell Biology</source><volume>160</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1083/jcb.200211046</pub-id><pub-id pub-id-type="pmid">12527753</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipolat</surname><given-names>S</given-names></name><name><surname>Martins de Brito</surname><given-names>O</given-names></name><name><surname>Dal Zilio</surname><given-names>B</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>OPA1 requires mitofusin 1 to promote mitochondrial fusion</article-title><source>PNAS</source><volume>101</volume><fpage>15927</fpage><lpage>15932</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407043101</pub-id><pub-id pub-id-type="pmid">15509649</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Calcium signaling</article-title><source>Cell</source><volume>131</volume><fpage>1047</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.028</pub-id><pub-id pub-id-type="pmid">18083096</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colom</surname><given-names>A</given-names></name><name><surname>Derivery</surname><given-names>E</given-names></name><name><surname>Soleimanpour</surname><given-names>S</given-names></name><name><surname>Tomba</surname><given-names>C</given-names></name><name><surname>Molin</surname><given-names>MD</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>González-Gaitán</surname><given-names>M</given-names></name><name><surname>Matile</surname><given-names>S</given-names></name><name><surname>Roux</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A fluorescent membrane tension probe</article-title><source>Nature Chemistry</source><volume>10</volume><fpage>1118</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1038/s41557-018-0127-3</pub-id><pub-id pub-id-type="pmid">30150727</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Brito</surname><given-names>OM</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mitofusin 2 tethers endoplasmic reticulum to mitochondria</article-title><source>Nature</source><volume>456</volume><fpage>605</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1038/nature07534</pub-id><pub-id pub-id-type="pmid">19052620</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bruyn</surname><given-names>PPH</given-names></name></person-group><year iso-8601-date="1946">1946</year><article-title>The amoeboid movement of the mammalian leukocyte in tissue culture</article-title><source>The Anatomical Record</source><volume>95</volume><fpage>177</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1002/ar.1090950209</pub-id><pub-id pub-id-type="pmid">20990822</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denisenko</surname><given-names>TV</given-names></name><name><surname>Gorbunova</surname><given-names>AS</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mitochondrial involvement in migration, invasion and metastasis</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>7</volume><elocation-id>355</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2019.00355</pub-id><pub-id pub-id-type="pmid">31921862</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derewenda</surname><given-names>U</given-names></name><name><surname>Oleksy</surname><given-names>A</given-names></name><name><surname>Stevenson</surname><given-names>AS</given-names></name><name><surname>Korczynska</surname><given-names>J</given-names></name><name><surname>Dauter</surname><given-names>Z</given-names></name><name><surname>Somlyo</surname><given-names>AP</given-names></name><name><surname>Otlewski</surname><given-names>J</given-names></name><name><surname>Somlyo</surname><given-names>AV</given-names></name><name><surname>Derewenda</surname><given-names>ZS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The crystal structure of RhoA in complex with the DH/PH fragment of PDZRhoGEF, an activator of the Ca(2+) sensitization pathway in smooth muscle</article-title><source>Structure</source><volume>12</volume><fpage>1955</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.1016/j.str.2004.09.003</pub-id><pub-id pub-id-type="pmid">15530360</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Discher</surname><given-names>DE</given-names></name><name><surname>Janmey</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tissue cells feel and respond to the stiffness of their substrate</article-title><source>Science</source><volume>310</volume><fpage>1139</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1126/science.1116995</pub-id><pub-id pub-id-type="pmid">16293750</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorn</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitofusins as mitochondrial anchors and tethers</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>142</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.04.016</pub-id><pub-id pub-id-type="pmid">32304672</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremov</surname><given-names>YM</given-names></name><name><surname>Velay-Lizancos</surname><given-names>M</given-names></name><name><surname>Weaver</surname><given-names>CJ</given-names></name><name><surname>Athamneh</surname><given-names>AI</given-names></name><name><surname>Zavattieri</surname><given-names>PD</given-names></name><name><surname>Suter</surname><given-names>DM</given-names></name><name><surname>Raman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Anisotropy vs isotropy in living cell indentation with AFM</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>5757</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-42077-1</pub-id><pub-id pub-id-type="pmid">30962474</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremov</surname><given-names>YM</given-names></name><name><surname>Suter</surname><given-names>DM</given-names></name><name><surname>Timashev</surname><given-names>PS</given-names></name><name><surname>Raman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>3D nanomechanical mapping of subcellular and sub-nuclear structures of living cells by multi-harmonic AFM with long-tip microcantilevers</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>529</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-04443-w</pub-id><pub-id pub-id-type="pmid">35017598</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Fissi</surname><given-names>N</given-names></name><name><surname>Rojo</surname><given-names>M</given-names></name><name><surname>Aouane</surname><given-names>A</given-names></name><name><surname>Karatas</surname><given-names>E</given-names></name><name><surname>Poliacikova</surname><given-names>G</given-names></name><name><surname>David</surname><given-names>C</given-names></name><name><surname>Royet</surname><given-names>J</given-names></name><name><surname>Rival</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitofusin gain and loss of function drive pathogenesis in <italic>Drosophila</italic> models of CMT2A neuropathy</article-title><source>EMBO Reports</source><volume>19</volume><elocation-id>e45241</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201745241</pub-id><pub-id pub-id-type="pmid">29898954</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filadi</surname><given-names>R</given-names></name><name><surname>Greotti</surname><given-names>E</given-names></name><name><surname>Turacchio</surname><given-names>G</given-names></name><name><surname>Luini</surname><given-names>A</given-names></name><name><surname>Pozzan</surname><given-names>T</given-names></name><name><surname>Pizzo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitofusin 2 ablation increases endoplasmic reticulum-mitochondria coupling</article-title><source>PNAS</source><volume>112</volume><fpage>E2174</fpage><lpage>E2181</lpage><pub-id pub-id-type="doi">10.1073/pnas.1504880112</pub-id><pub-id pub-id-type="pmid">25870285</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filadi</surname><given-names>R</given-names></name><name><surname>Pendin</surname><given-names>Di</given-names></name><name><surname>Pizzo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitofusin 2: from functions to disease</article-title><source>Cell Death &amp; Disease</source><volume>9</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41419-017-0023-6</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>IN</given-names></name><name><surname>Elliott</surname><given-names>CM</given-names></name><name><surname>Buchanan</surname><given-names>FG</given-names></name><name><surname>Downes</surname><given-names>CP</given-names></name><name><surname>Exton</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>12753</fpage><lpage>12758</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.18.12753</pub-id><pub-id pub-id-type="pmid">10212259</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Kitsis</surname><given-names>RN</given-names></name><name><surname>Fleischer</surname><given-names>JA</given-names></name><name><surname>Gavathiotis</surname><given-names>E</given-names></name><name><surname>Kornfeld</surname><given-names>OS</given-names></name><name><surname>Gong</surname><given-names>G</given-names></name><name><surname>Biris</surname><given-names>N</given-names></name><name><surname>Benz</surname><given-names>A</given-names></name><name><surname>Qvit</surname><given-names>N</given-names></name><name><surname>Donnelly</surname><given-names>SK</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Mennerick</surname><given-names>S</given-names></name><name><surname>Hodgson</surname><given-names>L</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Dorn</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Correcting mitochondrial fusion by manipulating mitofusin conformations</article-title><source>Nature</source><volume>540</volume><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/nature20156</pub-id><pub-id pub-id-type="pmid">27775718</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardel</surname><given-names>ML</given-names></name><name><surname>Schneider</surname><given-names>IC</given-names></name><name><surname>Aratyn-Schaus</surname><given-names>Y</given-names></name><name><surname>Waterman</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mechanical integration of actin and adhesion dynamics in cell migration</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>26</volume><fpage>315</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.011209.122036</pub-id><pub-id pub-id-type="pmid">19575647</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannone</surname><given-names>G</given-names></name><name><surname>Dubin-Thaler</surname><given-names>BJ</given-names></name><name><surname>Rossier</surname><given-names>O</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Chaga</surname><given-names>O</given-names></name><name><surname>Jiang</surname><given-names>G</given-names></name><name><surname>Beaver</surname><given-names>W</given-names></name><name><surname>Döbereiner</surname><given-names>HG</given-names></name><name><surname>Freund</surname><given-names>Y</given-names></name><name><surname>Borisy</surname><given-names>G</given-names></name><name><surname>Sheetz</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Lamellipodial actin mechanically links myosin activity with adhesion-site formation</article-title><source>Cell</source><volume>128</volume><fpage>561</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.12.039</pub-id><pub-id pub-id-type="pmid">17289574</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goll</surname><given-names>DE</given-names></name><name><surname>Thompson</surname><given-names>VF</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Cong</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The calpain system</article-title><source>Physiological Reviews</source><volume>83</volume><fpage>731</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1152/physrev.00029.2002</pub-id><pub-id pub-id-type="pmid">12843408</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Akhremitchev</surname><given-names>BB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Packing density and structural heterogeneity of insulin amyloid fibrils measured by AFM nanoindentation</article-title><source>Biomacromolecules</source><volume>7</volume><fpage>1630</fpage><lpage>1636</lpage><pub-id pub-id-type="doi">10.1021/bm0600724</pub-id><pub-id pub-id-type="pmid">16677048</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Rho GTPases and the actin cytoskeleton</article-title><source>Science</source><volume>279</volume><fpage>509</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1126/science.279.5350.509</pub-id><pub-id pub-id-type="pmid">9438836</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Rho GTPases and the control of cell behaviour</article-title><source>Biochemical Society Transactions</source><volume>33</volume><fpage>891</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1042/BST20050891</pub-id><pub-id pub-id-type="pmid">16246005</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertz</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1881">1881</year><article-title>On the elastic contact of elastic solids</article-title><source>Journal of Fur Die Reine Und Angewandte Mathematik</source><volume>92</volume><fpage>156</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1515/9783112342404</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Schell</surname><given-names>C</given-names></name><name><surname>Huber</surname><given-names>TB</given-names></name><name><surname>Şimşek</surname><given-names>AN</given-names></name><name><surname>Hersch</surname><given-names>N</given-names></name><name><surname>Merkel</surname><given-names>R</given-names></name><name><surname>Gompper</surname><given-names>G</given-names></name><name><surname>Sabass</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Traction force microscopy with optimized regularization and automated Bayesian parameter selection for comparing cells</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>539</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-36896-x</pub-id><pub-id pub-id-type="pmid">30679578</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudmon</surname><given-names>A</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II</article-title><source>The Biochemical Journal</source><volume>364</volume><fpage>593</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1042/BJ20020228</pub-id><pub-id pub-id-type="pmid">11931644</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutter</surname><given-names>JL</given-names></name><name><surname>Bechhoefer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Calibration of atomic-force microscope tips</article-title><source>Review of Scientific Instruments</source><volume>64</volume><fpage>1868</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1063/1.1143970</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikebe</surname><given-names>M</given-names></name><name><surname>Hartshorne</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Proteolysis of smooth muscle myosin by <italic>Staphylococcus aureus</italic> protease: preparation of heavy meromyosin and subfragment 1 with intact 20 000-dalton light chains</article-title><source>Biochemistry</source><volume>24</volume><fpage>2380</fpage><lpage>2387</lpage><pub-id pub-id-type="doi">10.1021/bi00330a038</pub-id><pub-id pub-id-type="pmid">3158349</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>N</given-names></name><name><surname>Eura</surname><given-names>Y</given-names></name><name><surname>Mihara</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity</article-title><source>Journal of Cell Science</source><volume>117</volume><fpage>6535</fpage><lpage>6546</lpage><pub-id pub-id-type="doi">10.1242/jcs.01565</pub-id><pub-id pub-id-type="pmid">15572413</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquemet</surname><given-names>G</given-names></name><name><surname>Hamidi</surname><given-names>H</given-names></name><name><surname>Ivaska</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Filopodia Quantification Using FiloQuant</article-title><source>Methods in Molecular Biology</source><volume>2040</volume><fpage>359</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9686-5_16</pub-id><pub-id pub-id-type="pmid">31432487</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="1985">1985</year><source>Contact Mechanics</source><publisher-name>Cambridge University Press</publisher-name><pub-id pub-id-type="doi">10.1017/CBO9781139171731</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells</article-title><source>Annual Review of Biochemistry</source><volume>68</volume><fpage>459</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.68.1.459</pub-id><pub-id pub-id-type="pmid">10872457</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamm</surname><given-names>KE</given-names></name><name><surname>Stull</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>The function of myosin and myosin light chain kinase phosphorylation in smooth muscle</article-title><source>Annual Review of Pharmacology and Toxicology</source><volume>25</volume><fpage>593</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1146/annurev.pa.25.040185.003113</pub-id><pub-id pub-id-type="pmid">2988424</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassianidou</surname><given-names>E</given-names></name><name><surname>Hughes</surname><given-names>JH</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Activation of ROCK and MLCK tunes regional stress fiber formation and mechanics via preferential myosin light chain phosphorylation</article-title><source>Molecular Biology of the Cell</source><volume>28</volume><fpage>3832</fpage><lpage>3843</lpage><pub-id pub-id-type="doi">10.1091/mbc.E17-06-0401</pub-id><pub-id pub-id-type="pmid">29046396</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K</given-names></name><name><surname>Kano</surname><given-names>Y</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001a</year><article-title>Stress fiber organization regulated by MLCK and Rho-kinase in cultured human fibroblasts</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>280</volume><fpage>C1669</fpage><lpage>C1679</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.2001.280.6.C1669</pub-id><pub-id pub-id-type="pmid">11350763</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>K</given-names></name><name><surname>Kano</surname><given-names>Y</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Onishi</surname><given-names>H</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Fujiwara</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001b</year><article-title>Rho-kinase--mediated contraction of isolated stress fibers</article-title><source>The Journal of Cell Biology</source><volume>153</volume><fpage>569</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1083/jcb.153.3.569</pub-id><pub-id pub-id-type="pmid">11331307</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerstein</surname><given-names>PC</given-names></name><name><surname>Patel</surname><given-names>KM</given-names></name><name><surname>Gomez</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Calpain-Mediated Proteolysis of Talin and FAK Regulates Adhesion Dynamics Necessary for Axon Guidance</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>1568</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2769-16.2016</pub-id><pub-id pub-id-type="pmid">28069919</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Kang</surname><given-names>WS</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Na</surname><given-names>HR</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name><name><surname>Park</surname><given-names>MH</given-names></name><name><surname>Paik</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Association between Mitofusin 2 Gene Polymorphisms and Late-Onset Alzheimer’s Disease in the Korean Population</article-title><source>Psychiatry Investigation</source><volume>14</volume><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.4306/pi.2017.14.1.81</pub-id><pub-id pub-id-type="pmid">28096879</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornmann</surname><given-names>B</given-names></name><name><surname>Currie</surname><given-names>E</given-names></name><name><surname>Collins</surname><given-names>SR</given-names></name><name><surname>Schuldiner</surname><given-names>M</given-names></name><name><surname>Nunnari</surname><given-names>J</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>An ER-mitochondria tethering complex revealed by a synthetic biology screen</article-title><source>Science</source><volume>325</volume><fpage>477</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1126/science.1175088</pub-id><pub-id pub-id-type="pmid">19556461</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>MC</given-names></name><name><surname>Kaluarachchi</surname><given-names>CP</given-names></name><name><surname>Lansakara</surname><given-names>TI</given-names></name><name><surname>Mellentine</surname><given-names>SQ</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Tivanski</surname><given-names>AV</given-names></name><name><surname>Tootle</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fascin limits Myosin activity within <italic>Drosophila</italic> border cells to control substrate stiffness and promote migration</article-title><source>eLife</source><volume>10</volume><elocation-id>e69836</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.69836</pub-id><pub-id pub-id-type="pmid">34698017</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lämmermann</surname><given-names>T</given-names></name><name><surname>Bader</surname><given-names>BL</given-names></name><name><surname>Monkley</surname><given-names>SJ</given-names></name><name><surname>Worbs</surname><given-names>T</given-names></name><name><surname>Wedlich-Söldner</surname><given-names>R</given-names></name><name><surname>Hirsch</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Förster</surname><given-names>R</given-names></name><name><surname>Critchley</surname><given-names>DR</given-names></name><name><surname>Fässler</surname><given-names>R</given-names></name><name><surname>Sixt</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rapid leukocyte migration by integrin-independent flowing and squeezing</article-title><source>Nature</source><volume>453</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nature06887</pub-id><pub-id pub-id-type="pmid">18451854</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauffenburger</surname><given-names>DA</given-names></name><name><surname>Horwitz</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Cell migration: a physically integrated molecular process</article-title><source>Cell</source><volume>84</volume><fpage>359</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)81280-5</pub-id><pub-id pub-id-type="pmid">8608589</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Sterky</surname><given-names>FH</given-names></name><name><surname>Mourier</surname><given-names>A</given-names></name><name><surname>Terzioglu</surname><given-names>M</given-names></name><name><surname>Cullheim</surname><given-names>S</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name><name><surname>Larsson</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>4827</fpage><lpage>4835</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds352</pub-id><pub-id pub-id-type="pmid">22914740</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Redmond</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CaMKIIbeta binding to stable F-actin in vivo regulates F-actin filament stability</article-title><source>PNAS</source><volume>105</volume><fpage>15791</fpage><lpage>15796</lpage><pub-id pub-id-type="doi">10.1073/pnas.0804399105</pub-id><pub-id pub-id-type="pmid">18840684</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>HB</given-names></name><name><surname>Dembo</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>YL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cell movement is guided by the rigidity of the substrate</article-title><source>Biophysical Journal</source><volume>79</volume><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(00)76279-5</pub-id><pub-id pub-id-type="pmid">10866943</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machacek</surname><given-names>M</given-names></name><name><surname>Hodgson</surname><given-names>L</given-names></name><name><surname>Welch</surname><given-names>C</given-names></name><name><surname>Elliott</surname><given-names>H</given-names></name><name><surname>Pertz</surname><given-names>O</given-names></name><name><surname>Nalbant</surname><given-names>P</given-names></name><name><surname>Abell</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>GL</given-names></name><name><surname>Hahn</surname><given-names>KM</given-names></name><name><surname>Danuser</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Coordination of Rho GTPase activities during cell protrusion</article-title><source>Nature</source><volume>461</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1038/nature08242</pub-id><pub-id pub-id-type="pmid">19693013</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maianski</surname><given-names>NA</given-names></name><name><surname>Mul</surname><given-names>FPJ</given-names></name><name><surname>van Buul</surname><given-names>JD</given-names></name><name><surname>Roos</surname><given-names>D</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils</article-title><source>Blood</source><volume>99</volume><fpage>672</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1182/blood.v99.2.672</pub-id><pub-id pub-id-type="pmid">11781253</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>SK</given-names></name><name><surname>Hanson</surname><given-names>DA</given-names></name><name><surname>Schlaepfer</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Focal adhesion kinase: in command and control of cell motility</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>6</volume><fpage>56</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/nrm1549</pub-id><pub-id pub-id-type="pmid">15688067</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naon</surname><given-names>D</given-names></name><name><surname>Zaninello</surname><given-names>M</given-names></name><name><surname>Giacomello</surname><given-names>M</given-names></name><name><surname>Varanita</surname><given-names>T</given-names></name><name><surname>Grespi</surname><given-names>F</given-names></name><name><surname>Lakshminaranayan</surname><given-names>S</given-names></name><name><surname>Serafini</surname><given-names>A</given-names></name><name><surname>Semenzato</surname><given-names>M</given-names></name><name><surname>Herkenne</surname><given-names>S</given-names></name><name><surname>Hernández-Alvarez</surname><given-names>MI</given-names></name><name><surname>Zorzano</surname><given-names>A</given-names></name><name><surname>De Stefani</surname><given-names>D</given-names></name><name><surname>Dorn</surname><given-names>GW</given-names></name><name><surname>Scorrano</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether</article-title><source>PNAS</source><volume>113</volume><fpage>11249</fpage><lpage>11254</lpage><pub-id pub-id-type="doi">10.1073/pnas.1606786113</pub-id><pub-id pub-id-type="pmid">27647893</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobes</surname><given-names>CD</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia</article-title><source>Cell</source><volume>81</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90370-4</pub-id><pub-id pub-id-type="pmid">7536630</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nobes</surname><given-names>CD</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Rho GTPases control polarity, protrusion, and adhesion during cell movement</article-title><source>The Journal of Cell Biology</source><volume>144</volume><fpage>1235</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1083/jcb.144.6.1235</pub-id><pub-id pub-id-type="pmid">10087266</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakes</surname><given-names>PW</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Marchetti</surname><given-names>MC</given-names></name><name><surname>Gardel</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Geometry regulates traction stresses in adherent cells</article-title><source>Biophysical Journal</source><volume>107</volume><fpage>825</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2014.06.045</pub-id><pub-id pub-id-type="pmid">25140417</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okabe</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>YN</given-names></name><name><surname>Kohu</surname><given-names>K</given-names></name><name><surname>Ohwada</surname><given-names>S</given-names></name><name><surname>Morishita</surname><given-names>Y</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in the beta-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling</article-title><source>The Journal of Biological Chemistry</source><volume>278</volume><fpage>9920</fpage><lpage>9927</lpage><pub-id pub-id-type="doi">10.1074/jbc.M208872200</pub-id><pub-id pub-id-type="pmid">12531901</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>KI</given-names></name><name><surname>Narayanan</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of CaMKII as an F-actin-bundling protein crucial for maintenance of dendritic spine structure</article-title><source>PNAS</source><volume>104</volume><fpage>6418</fpage><lpage>6423</lpage><pub-id pub-id-type="doi">10.1073/pnas.0701656104</pub-id><pub-id pub-id-type="pmid">17404223</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Leary</surname><given-names>H</given-names></name><name><surname>Lasda</surname><given-names>E</given-names></name><name><surname>Bayer</surname><given-names>KU</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>CaMKIIbeta association with the actin cytoskeleton is regulated by alternative splicing</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>4656</fpage><lpage>4665</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-03-0252</pub-id><pub-id pub-id-type="pmid">16928958</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="software"><person-group person-group-type="author"><collab>OpenCV contributors</collab></person-group><year iso-8601-date="2022">2022</year><data-title>Opencv</data-title><version designator="4.7.0">4.7.0</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/opencv/opencv">https://github.com/opencv/opencv</ext-link></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pareyson</surname><given-names>D</given-names></name><name><surname>Saveri</surname><given-names>P</given-names></name><name><surname>Sagnelli</surname><given-names>A</given-names></name><name><surname>Piscosquito</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mitochondrial dynamics and inherited peripheral nerve diseases</article-title><source>Neuroscience Letters</source><volume>596</volume><fpage>66</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2015.04.001</pub-id><pub-id pub-id-type="pmid">25847151</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>JT</given-names></name><name><surname>Horwitz</surname><given-names>AR</given-names></name><name><surname>Schwartz</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell adhesion: integrating cytoskeletal dynamics and cellular tension</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>11</volume><fpage>633</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/nrm2957</pub-id><pub-id pub-id-type="pmid">20729930</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parys</surname><given-names>JB</given-names></name><name><surname>De Smedt</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Inositol 1,4,5-trisphosphate and its receptors</article-title><source>Advances in Experimental Medicine and Biology</source><volume>740</volume><fpage>255</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-2888-2_11</pub-id><pub-id pub-id-type="pmid">22453946</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelham</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>Yl</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Cell locomotion and focal adhesions are regulated by substrate flexibility</article-title><source>PNAS</source><volume>94</volume><fpage>13661</fpage><lpage>13665</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.25.13661</pub-id><pub-id pub-id-type="pmid">9391082</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penzes</surname><given-names>P</given-names></name><name><surname>Cahill</surname><given-names>ME</given-names></name><name><surname>Jones</surname><given-names>KA</given-names></name><name><surname>Srivastava</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Convergent CaMK and RacGEF signals control dendritic structure and function</article-title><source>Trends in Cell Biology</source><volume>18</volume><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.07.002</pub-id><pub-id pub-id-type="pmid">18701290</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Borisy</surname><given-names>GG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cellular motility driven by assembly and disassembly of actin filaments</article-title><source>Cell</source><volume>112</volume><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(03)00120-x</pub-id><pub-id pub-id-type="pmid">12600310</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridley</surname><given-names>AJ</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors</article-title><source>Cell</source><volume>70</volume><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90163-7</pub-id><pub-id pub-id-type="pmid">1643657</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>AG</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Krezel</surname><given-names>AM</given-names></name><name><surname>Rumsey</surname><given-names>JM</given-names></name><name><surname>Alberti</surname><given-names>JM</given-names></name><name><surname>Knight</surname><given-names>WC</given-names></name><name><surname>Biris</surname><given-names>N</given-names></name><name><surname>Zacharioudakis</surname><given-names>E</given-names></name><name><surname>Janetka</surname><given-names>JW</given-names></name><name><surname>Baloh</surname><given-names>RH</given-names></name><name><surname>Kitsis</surname><given-names>RN</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Townsend</surname><given-names>RR</given-names></name><name><surname>Gavathiotis</surname><given-names>E</given-names></name><name><surname>Dorn</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A</article-title><source>Science</source><volume>360</volume><fpage>336</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1126/science.aao1785</pub-id><pub-id pub-id-type="pmid">29674596</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabass</surname><given-names>B</given-names></name><name><surname>Gardel</surname><given-names>ML</given-names></name><name><surname>Waterman</surname><given-names>CM</given-names></name><name><surname>Schwarz</surname><given-names>US</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>High resolution traction force microscopy based on experimental and computational advances</article-title><source>Biophysical Journal</source><volume>94</volume><fpage>207</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1529/biophysj.107.113670</pub-id><pub-id pub-id-type="pmid">17827246</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>S</given-names></name><name><surname>Oakes</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Stress fiber strain recognition by the LIM protein testin is cryptic and mediated by RhoA</article-title><source>Molecular Biology of the Cell</source><volume>32</volume><fpage>1758</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1091/mbc.E21-03-0156</pub-id><pub-id pub-id-type="pmid">34038160</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saneyoshi</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Ca2+ and Rho GTPase signaling pathways underlying activity-dependent actin remodeling at dendritic spines</article-title><source>Cytoskeleton</source><volume>69</volume><fpage>545</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1002/cm.21037</pub-id><pub-id pub-id-type="pmid">22566410</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santel</surname><given-names>A</given-names></name><name><surname>Fuller</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Control of mitochondrial morphology by a human mitofusin</article-title><source>Journal of Cell Science</source><volume>114</volume><fpage>867</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1242/jcs.114.5.867</pub-id><pub-id pub-id-type="pmid">11181170</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seetharaman</surname><given-names>S</given-names></name><name><surname>Etienne-Manneville</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cytoskeletal crosstalk in cell migration</article-title><source>Trends in Cell Biology</source><volume>30</volume><fpage>720</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2020.06.004</pub-id><pub-id pub-id-type="pmid">32674938</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The Ca-calmodulin-dependent protein kinase cascade</article-title><source>Trends in Biochemical Sciences</source><volume>24</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/s0968-0004(99)01383-3</pub-id><pub-id pub-id-type="pmid">10366852</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strickland</surname><given-names>AV</given-names></name><name><surname>Rebelo</surname><given-names>AP</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Bolon</surname><given-names>B</given-names></name><name><surname>Silva</surname><given-names>JP</given-names></name><name><surname>Wen</surname><given-names>R</given-names></name><name><surname>Züchner</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model</article-title><source>Journal of the Peripheral Nervous System</source><volume>19</volume><fpage>152</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1111/jns5.12066</pub-id><pub-id pub-id-type="pmid">24862862</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stull</surname><given-names>JT</given-names></name><name><surname>Lin</surname><given-names>PJ</given-names></name><name><surname>Krueger</surname><given-names>JK</given-names></name><name><surname>Trewhella</surname><given-names>J</given-names></name><name><surname>Zhi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Myosin light chain kinase: functional domains and structural motifs</article-title><source>Acta Physiologica Scandinavica</source><volume>164</volume><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1111/j.1365-201x.1998.tb10699.x</pub-id><pub-id pub-id-type="pmid">9887970</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Day</surname><given-names>RN</given-names></name><name><surname>Periasamy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Investigating protein-protein interactions in living cells using fluorescence lifetime imaging microscopy</article-title><source>Nature Protocols</source><volume>6</volume><fpage>1324</fpage><lpage>1340</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.364</pub-id><pub-id pub-id-type="pmid">21886099</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Rho as a regulator of the cytoskeleton</article-title><source>Trends in Biochemical Sciences</source><volume>20</volume><fpage>227</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/s0968-0004(00)89022-2</pub-id><pub-id pub-id-type="pmid">7543224</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>SY</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>CS</given-names></name><name><surname>Janmey</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cell shape and substrate rigidity both regulate cell stiffness</article-title><source>Biophysical Journal</source><volume>100</volume><fpage>L25</fpage><lpage>L27</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.12.3744</pub-id><pub-id pub-id-type="pmid">21354386</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolias</surname><given-names>KF</given-names></name><name><surname>Bikoff</surname><given-names>JB</given-names></name><name><surname>Burette</surname><given-names>A</given-names></name><name><surname>Paradis</surname><given-names>S</given-names></name><name><surname>Harrar</surname><given-names>D</given-names></name><name><surname>Tavazoie</surname><given-names>S</given-names></name><name><surname>Weinberg</surname><given-names>RJ</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines</article-title><source>Neuron</source><volume>45</volume><fpage>525</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.01.024</pub-id><pub-id pub-id-type="pmid">15721239</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Tomato990</collab></person-group><year iso-8601-date="2023">2023</year><data-title>CellEdgeAreaPercent</data-title><version designator="swh:1:rev:b91f744227e12e5ed93cc0f4628307fdcd273052">swh:1:rev:b91f744227e12e5ed93cc0f4628307fdcd273052</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:bbf38682690185a5a4de1d48a19ff01a5f7b8c97;origin=https://github.com/tomato990/CellEdgeAreaPercent;visit=swh:1:snp:39185bdd5fa846eacaf6974a191dcc36e1193557;anchor=swh:1:rev:b91f744227e12e5ed93cc0f4628307fdcd273052">https://archive.softwareheritage.org/swh:1:dir:bbf38682690185a5a4de1d48a19ff01a5f7b8c97;origin=https://github.com/tomato990/CellEdgeAreaPercent;visit=swh:1:snp:39185bdd5fa846eacaf6974a191dcc36e1193557;anchor=swh:1:rev:b91f744227e12e5ed93cc0f4628307fdcd273052</ext-link></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Totsukawa</surname><given-names>G</given-names></name><name><surname>Yamakita</surname><given-names>Y</given-names></name><name><surname>Yamashiro</surname><given-names>S</given-names></name><name><surname>Hartshorne</surname><given-names>DJ</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts</article-title><source>The Journal of Cell Biology</source><volume>150</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.4.797</pub-id><pub-id pub-id-type="pmid">10953004</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>FC</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Ca2+ pulses control local cycles of lamellipodia retraction and adhesion along the front of migrating cells</article-title><source>Current Biology</source><volume>22</volume><fpage>837</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2012.03.037</pub-id><pub-id pub-id-type="pmid">22521790</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>FC</given-names></name><name><surname>Kuo</surname><given-names>GH</given-names></name><name><surname>Chang</surname><given-names>SW</given-names></name><name><surname>Tsai</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ca2+ signaling in cytoskeletal reorganization, cell migration, and cancer metastasis</article-title><source>BioMed Research International</source><volume>2015</volume><elocation-id>409245</elocation-id><pub-id pub-id-type="doi">10.1155/2015/409245</pub-id><pub-id pub-id-type="pmid">25977921</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehata</surname><given-names>M</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Kawahara</surname><given-names>T</given-names></name><name><surname>Morishita</surname><given-names>T</given-names></name><name><surname>Tamakawa</surname><given-names>H</given-names></name><name><surname>Yamagami</surname><given-names>K</given-names></name><name><surname>Inui</surname><given-names>J</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension</article-title><source>Nature</source><volume>389</volume><fpage>990</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1038/40187</pub-id><pub-id pub-id-type="pmid">9353125</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallese</surname><given-names>F</given-names></name><name><surname>Catoni</surname><given-names>C</given-names></name><name><surname>Cieri</surname><given-names>D</given-names></name><name><surname>Barazzuol</surname><given-names>L</given-names></name><name><surname>Ramirez</surname><given-names>O</given-names></name><name><surname>Calore</surname><given-names>V</given-names></name><name><surname>Bonora</surname><given-names>M</given-names></name><name><surname>Giamogante</surname><given-names>F</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name><name><surname>Brini</surname><given-names>M</given-names></name><name><surname>Calì</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An expanded palette of improved SPLICS reporters detects multiple organelle contacts in vitro and in vivo</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6069</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19892-6</pub-id><pub-id pub-id-type="pmid">33247103</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoeven</surname><given-names>K</given-names></name><name><surname>Claeys</surname><given-names>KG</given-names></name><name><surname>Züchner</surname><given-names>S</given-names></name><name><surname>Schröder</surname><given-names>JM</given-names></name><name><surname>Weis</surname><given-names>J</given-names></name><name><surname>Ceuterick</surname><given-names>C</given-names></name><name><surname>Jordanova</surname><given-names>A</given-names></name><name><surname>Nelis</surname><given-names>E</given-names></name><name><surname>De Vriendt</surname><given-names>E</given-names></name><name><surname>Van Hul</surname><given-names>M</given-names></name><name><surname>Seeman</surname><given-names>P</given-names></name><name><surname>Mazanec</surname><given-names>R</given-names></name><name><surname>Saifi</surname><given-names>GM</given-names></name><name><surname>Szigeti</surname><given-names>K</given-names></name><name><surname>Mancias</surname><given-names>P</given-names></name><name><surname>Butler</surname><given-names>IJ</given-names></name><name><surname>Kochanski</surname><given-names>A</given-names></name><name><surname>Ryniewicz</surname><given-names>B</given-names></name><name><surname>De Bleecker</surname><given-names>J</given-names></name><name><surname>Van den Bergh</surname><given-names>P</given-names></name><name><surname>Verellen</surname><given-names>C</given-names></name><name><surname>Van Coster</surname><given-names>R</given-names></name><name><surname>Goemans</surname><given-names>N</given-names></name><name><surname>Auer-Grumbach</surname><given-names>M</given-names></name><name><surname>Robberecht</surname><given-names>W</given-names></name><name><surname>Milic Rasic</surname><given-names>V</given-names></name><name><surname>Nevo</surname><given-names>Y</given-names></name><name><surname>Tournev</surname><given-names>I</given-names></name><name><surname>Guergueltcheva</surname><given-names>V</given-names></name><name><surname>Roelens</surname><given-names>F</given-names></name><name><surname>Vieregge</surname><given-names>P</given-names></name><name><surname>Vinci</surname><given-names>P</given-names></name><name><surname>Moreno</surname><given-names>MT</given-names></name><name><surname>Christen</surname><given-names>H-J</given-names></name><name><surname>Shy</surname><given-names>ME</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><name><surname>Vance</surname><given-names>JM</given-names></name><name><surname>De Jonghe</surname><given-names>P</given-names></name><name><surname>Timmerman</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2</article-title><source>Brain</source><volume>129</volume><fpage>2093</fpage><lpage>2102</lpage><pub-id pub-id-type="doi">10.1093/brain/awl126</pub-id><pub-id pub-id-type="pmid">16714318</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Manzanares</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Adelstein</surname><given-names>RS</given-names></name><name><surname>Horwitz</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Non-muscle myosin II takes centre stage in cell adhesion and migration</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>10</volume><fpage>778</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/nrm2786</pub-id><pub-id pub-id-type="pmid">19851336</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vichai</surname><given-names>V</given-names></name><name><surname>Kirtikara</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Sulforhodamine B colorimetric assay for cytotoxicity screening</article-title><source>Nature Protocols</source><volume>1</volume><fpage>1112</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.179</pub-id><pub-id pub-id-type="pmid">17406391</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakatsuki</surname><given-names>T</given-names></name><name><surname>Wysolmerski</surname><given-names>RB</given-names></name><name><surname>Elson</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Mechanics of cell spreading: role of myosin II</article-title><source>Journal of Cell Science</source><volume>116</volume><fpage>1617</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1242/jcs.00340</pub-id><pub-id pub-id-type="pmid">12640045</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Impaired balance of mitochondrial fission and fusion in Alzheimer’s disease</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>9090</fpage><lpage>9103</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1357-09.2009</pub-id><pub-id pub-id-type="pmid">19605646</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SY</given-names></name><name><surname>Ulrich</surname><given-names>TA</given-names></name><name><surname>Deleyrolle</surname><given-names>LP</given-names></name><name><surname>MacKay</surname><given-names>JL</given-names></name><name><surname>Lin</surname><given-names>JMG</given-names></name><name><surname>Martuscello</surname><given-names>RT</given-names></name><name><surname>Jundi</surname><given-names>MA</given-names></name><name><surname>Reynolds</surname><given-names>BA</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion</article-title><source>Cancer Research</source><volume>75</volume><fpage>1113</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-3426</pub-id><pub-id pub-id-type="pmid">25634210</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cellular and molecular mechanisms of fibrosis</article-title><source>The Journal of Pathology</source><volume>214</volume><fpage>199</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1002/path.2277</pub-id><pub-id pub-id-type="pmid">18161745</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z</given-names></name><name><surname>Srivastava</surname><given-names>DP</given-names></name><name><surname>Photowala</surname><given-names>H</given-names></name><name><surname>Kai</surname><given-names>L</given-names></name><name><surname>Cahill</surname><given-names>ME</given-names></name><name><surname>Woolfrey</surname><given-names>KM</given-names></name><name><surname>Shum</surname><given-names>CY</given-names></name><name><surname>Surmeier</surname><given-names>DJ</given-names></name><name><surname>Penzes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines</article-title><source>Neuron</source><volume>56</volume><fpage>640</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.005</pub-id><pub-id pub-id-type="pmid">18031682</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Ma</surname><given-names>D</given-names></name><name><surname>MacPherson</surname><given-names>KP</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Bi</surname><given-names>C</given-names></name><name><surname>Kwok</surname><given-names>T</given-names></name><name><surname>Chubykin</surname><given-names>AA</given-names></name><name><surname>Yin</surname><given-names>P</given-names></name><name><surname>Calve</surname><given-names>S</given-names></name><name><surname>Landreth</surname><given-names>GE</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Three-dimensional nanoscopy of whole cells and tissues with in situ point spread function retrieval</article-title><source>Nature Methods</source><volume>17</volume><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-0816-x</pub-id><pub-id pub-id-type="pmid">32371980</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>Z</given-names></name><name><surname>Giachini</surname><given-names>FRC</given-names></name><name><surname>Tostes</surname><given-names>RC</given-names></name><name><surname>Webb</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>29</volume><fpage>1657</fpage><lpage>1663</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.109.190892</pub-id><pub-id pub-id-type="pmid">19759375</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wolff</surname><given-names>DW</given-names></name><name><surname>Abel</surname><given-names>PW</given-names></name><name><surname>Tu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mitochondrial dynamics regulates migration and invasion of breast cancer cells</article-title><source>Oncogene</source><volume>32</volume><fpage>4814</fpage><lpage>4824</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.494</pub-id><pub-id pub-id-type="pmid">23128392</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Jeffries</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Staiger</surname><given-names>CJ</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neutrophil-specific knockout demonstrates a role for mitochondria in regulating neutrophil motility in zebrafish</article-title><source>Disease Models &amp; Mechanisms</source><volume>11</volume><elocation-id>dmm033027</elocation-id><pub-id pub-id-type="doi">10.1242/dmm.033027</pub-id><pub-id pub-id-type="pmid">29590639</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Hsu</surname><given-names>AY</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Syahirah</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Jeffries</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Mohammad</surname><given-names>H</given-names></name><name><surname>Seleem</surname><given-names>MN</given-names></name><name><surname>Umulis</surname><given-names>D</given-names></name><name><surname>Deng</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitofusin 2 regulates neutrophil adhesive migration and the actin cytoskeleton</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs248880</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.248880</pub-id><pub-id pub-id-type="pmid">32788232</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Wild-type MEF</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-2991</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Mfn1</italic>-null MEF</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-2992</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Mfn2</italic>-null MEF</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-2993</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (human)</td><td align="left" valign="bottom">HEK 293T/17</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">CRL-11268</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">MSCV-puro-Mfn1</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">MFN1 overexpression</td></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">MSCV-puro-Mfn2</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">MFN2 rescue</td></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">MSCV-puro-mito-GFP-ER</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expressing the artificial tethering structure in MEFs</td></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">SPLICS Mt-ER Long P2A</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">#164107</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">MSCV-puro-CaMKII-WT</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">CaMKIIalpha expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">MSCV-puro-CaMKII-DN</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Dominant negative CaMKIIalpha expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">MSCV-puro-MLCK-CA</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Constitutive active MLCK expression</td></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">MSCV-puro-MRLC-GFP</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">MRLC-GFP expression</td></tr><tr><td align="left" valign="bottom">Transfected construct</td><td align="left" valign="bottom">pCMV-dR8.2 dvpr</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">#8455</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct</td><td align="left" valign="bottom">pCMV-VSV-G</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">#8454</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">Lipofectamine 3000</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">L3000015</td><td align="left" valign="bottom">Transfection reagent</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PLKO.1-Puro-ctrl (SHC003) (plasmid)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">SHC 003</td><td align="left" valign="bottom">Control plasmid for knock-down MEF lines</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PLKO.1-Puro-shROCK (plasmid)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">TRCN0000022903</td><td align="left" valign="bottom">Knockdown ROCK in MEFs</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PLKO.1-Puro-shMLCK (plasmid)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">TRCN0000024037</td><td align="left" valign="bottom">Knockdown MLCK in MEFs</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MSCV-mfn2 insert F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CACGATAATACCATGGGCCACCATGTCCCTGCTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MSCV-mfn2 insert R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TCTAGAGTCGCGGCCGCTTACTTGTACAGCTCGTCCATGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MSCV-mfn1 insert R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TCGACTCTAGAGTCGCGGCCGCTTACTTGTACAGCTCGTCCATGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mfn2 into plix-Nsil-F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AAAACCCCGGTCCTATGCATATGTCCCTGCTCTTCTCTCGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mfn2 into plix-BamHI-R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CCCCAACCCCGGATCCTTATCTGCTGGGCTGCAGGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Camk2a-MSCV-F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AATTAGATCTCTCGAGGCCACCATGGTGAGCAAGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Camk2a-MSCV-R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CTACCCGGTAGAATTCATTCGGCGAAGCAAGAGCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ER-mito F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AATTAGATCTCTCGAGATGGCAATCCAGTTGCGTTCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">ER-mito R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">ATTTACGTAGCGGCCGCTTAAGATACATTGATGAGTTTGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MRLC-GFP F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">AATTAGATCTCTCGAGGCCACCATGGTGAGCAAGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MRLC-GFP R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">CTACCCGGTAGAATTCGCCCGCGGTCAGTCATCTTTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MLCK-CA F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">attagatctctcgagactagtcgactggatcc</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">MLCK-CA R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ccggtagaattcagatcttgggtgggttaattaa</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BAPTA</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#11706</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Y27632</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#10005583</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CK666</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#29038</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">STO-609 acetate</td><td align="left" valign="bottom">Biotechne</td><td align="left" valign="bottom">#1551</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">A23187</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#11016</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Blebbistatin</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#13013</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Oligomycin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">#495455</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FCCP</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C2920</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rotenone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">#557368</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Antimycin A</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">A8674</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CAS 1090893</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">#553511</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">RhoA inhibitor-I</td><td align="left" valign="bottom">Cytoskeleton, Inc</td><td align="left" valign="bottom">#CT-04</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FK-506</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#10007965</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">FAK14</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#14485</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BMS-5</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#21072</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ML-7</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">#11801</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DAPI</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">D1306</td><td align="left" valign="bottom">1 µg/ml for IF staining</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mfn2 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">9482S</td><td align="left" valign="bottom">IF(1:200), WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mfn1 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab126575</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-pan-CaMKII (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#3362</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phosphor-CaMKII (Thr286) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#12716</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phosphor-myosin light chain 2 (Ser19) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#3671</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-myosin light chain 2 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#3672</td><td align="left" valign="bottom">IF (1:200), WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho-PAK (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#2605S</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-PAK1/2/3 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">#2604</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Vinculin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">#V9131</td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">HRP AffiniPure anti-rabbit IgG (goat polyclonal)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">#111-035-003</td><td align="left" valign="bottom">WB (1:2500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG Alexa Fluor 680 (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">#A28183</td><td align="left" valign="bottom">WB (1:2500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG Alexa Fluor Plus 800 (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">#A32735</td><td align="left" valign="bottom">WB (1:2500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit Alexa Fluor 488, (chicken polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">#A-21441</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse Alexa Fluor 568, (Goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">#A-11004</td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">PLKO.1-Puro (plasmid)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_10878">Addgene_10878</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Platelet-Derived Growth Factor-BB human</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">P3201</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">AIP</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">#5959/1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">siRNA: nontargeting control</td><td align="left" valign="bottom">Thermo Fisher</td><td align="char" char="." valign="bottom">4390843</td><td align="left" valign="bottom">Silencer Select</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Rac1 Pull-Down Activation Assay Biochem Kit (Bead Pull-Down Format)</td><td align="left" valign="bottom">Cytoskeleton, Inc</td><td align="left" valign="bottom">#BK035</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RhoA Pull-Down Activation Assay Biochem Kit (Bead Pull-Down Format)</td><td align="left" valign="bottom">Cytoskeleton, Inc</td><td align="left" valign="bottom">#BK036</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Fluo-4 Calcium Imaging Kit</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">F10489</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Seahorse XF Cell Mito Stress Test Kit</td><td align="left" valign="bottom">Agilent Technologies</td><td align="left" valign="bottom">#103015-100</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Flipper-TR</td><td align="left" valign="bottom">Cytoskeleton</td><td align="left" valign="bottom">CY-SC020</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">In-Fusion HD Cloning</td><td align="left" valign="bottom">Clontech</td><td align="char" char="." valign="bottom">639647</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Python</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">See “Immunostaning and confocal imaging” and “traction force microscopy and analysis”</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ software</td><td align="left" valign="bottom">ImageJ (<ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism 6</td><td align="left" valign="bottom">GraphPad Prism (<ext-link ext-link-type="uri" xlink:href="https://graphpad.com">https://graphpad.com</ext-link>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.88828.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>This important article presents evidence for a special role of mitofusin-2, not shared with mitofusin-1, in regulating the actin cytoskeleton through calcium, RhoA, and actomyosin contractility. The evidence is compelling and uses a variety of techniques, including creative approaches, to investigate mitofusin-2’s role in ER-mitochondrial tethering. The article will be of interest to investigators studying mitofusins, mitochondrial fission/fusion, and the actin cytoskeleton.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.88828.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p>[Editors' note: this paper was reviewed by <ext-link ext-link-type="uri" xlink:href="https://www.reviewcommons.org/">Review Commons</ext-link>.]</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.88828.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>General Statements</p></disp-quote><p>First, we would like to reiterate the reviewer’s comment regarding the significance of our work:</p><p>R1: “There is a growing field of mitochondrial biology and how it relates to cell migration. This paper examines the function of a key mitochondrial morphology regulator, MFN2, and dissects the role for MFN2 in migration at the level of cytoskeletal regulation. We think that this is interesting and that it's clear that MFN2 has multiple functions in the cell.”</p><p>R2: “Delineating the role of Mfn2 in cell migration will represent a good, fundamental contribution to the field of cell migration. The reviewer finds this manuscript to be conceptually interesting.”</p><p>R3: “The main novelty here appears to be the connection between excess cytoplasmic calcium, MFN2 loss, and RhoA/myosin activation. This is interesting and a useful addition to the literature.”</p><p>We agree with the reviewers that the scope of our study is limited to a fundamental cell biology question of how mfn2 regulates the actin cytoskeleton. In particular, the formation of an atypical peripheral actin band. We have restructured the manuscript to focus better on cell biology. Our results do not directly address MFN2-related disease or the formation of peripheral actin bands in vivo. Nevertheless, our work contributes to a fundamental understanding of cell biology that sets the foundation for future work in MFN2-related disease mechanisms in vivo.</p><disp-quote content-type="editor-comment"><p>Point-by-point description of the revisions</p><p>Reviewer #1:</p><p>– Key conclusions that were less convincing:</p><p>– RhoA and NMII are in the title as mechanistic downstream regulators of CaM, but the results in Figure 8 call into question the role of RhoA. Why does RhoA activation not influence cell size and circularity? Can you overexpress MRLC-GFP and inhibit Rho and restore the wt phenotype? The role of NMII is also not clear – why does overexpressing MLCK-CA not have a phenotype but overexpressing MLCK downstream target MRLC show the phenotype? Are there any alternative pathways to regulate MRLC? It's not being discussed or described in 6D's schematic.</p></disp-quote><p>Rho activation usually leads to the formation of more stress fibers and therefore does not lead to decreased cell size and increased circularity observed in MFN2 KO. The phenotype is restored by either ROCK or MLCK knockdown. We have discussed in the main text that the formation of PAB requires both RhoA and NMII activation under restricted spatiotemporal control.</p><p>MRLC has three major regulators (Ikebe and Hartshorne, 1985; Isotani et al., 2004). As we discussed, MLCK and ROCK phosphorylate MRLC at either Ser19 or Ser19 and Thr18. MRLC is dephosphorylated and inactivated by its phosphatase MLCP. We tried to knock down MLCP in wt MEF cells but failed to see any cell morphology changes (data not shown).</p><p>We were also surprised to see MRLC-GFP overexpression with Rho Activator can phenocopy PAB, but “MLCK-CA + Rho Activator” failed to. We believe it is because MLCK-CA constitutively over-activates a broad range of downstream effectors while overexpressing MRLC mimics endogenous activation or NMII alone. Also, only a proportion of cells acquired PAB structure under Rho Activator and MRLC overexpression, which indicates PAB formation also requires specific spatiotemporal controls.</p><disp-quote content-type="editor-comment"><p>Rewrite for clarity</p><p>– The role of ER/mito contacts in the system was unclear (since ER/mito contacts were not observed nor evaluated directly).</p></disp-quote><p>We have included additional data to measure ER/mito contacts in MEFs. Our result is consistent with numerous previous reports that MFN2 regulates ER/mito contacts. The data is now included in Figure S3.</p><disp-quote content-type="editor-comment"><p>– What role does focal adhesions have on PAB formation or any part of the model – There were results showing larger focal adhesions in the MFN2-/- cells, but not sure how this fits in with the bigger picture of contractility and PABs, and focal adhesions were not in the model in Figure 5.</p></disp-quote><p>Focal adhesion and actomyosin are tightly coupled, and our work focuses on the actin network. Our model did not include FAs since FA is not a significant focus in this study.</p><disp-quote content-type="editor-comment"><p>– Whether regulating calcium impacts PAB formation</p></disp-quote><p>Calcium likely regulates PAB formation. We have shown PAB cell percentage decreases in mfn2-/- with ER-mito tethering contrast in Figure S3.</p><disp-quote content-type="editor-comment"><p>– The role of PABs in migration is also unclear – can you affect PAB formation or get rid of PABs and quantify cell migration?</p></disp-quote><p>Our data suggest that PAB formation and cell migration are inversely correlated. Since PAB results from a contractile actin band on the cell periphery, its role in defective cell spreading and migration is expected. We demonstrated that MLCK and ROCK knockdown reduced PABs and rescued cell spreading.</p><disp-quote content-type="editor-comment"><p>– It was hard to understand the correlation between the membrane tension of MFN2-/- cells and their ability to spread on softer substrates. How does this result fit in with the overarching model?</p></disp-quote><p>Reduced membrane tension is presumably associated with decreased cell spreading. Softer substrates attenuate the mechanical force on focal adhesion proteins and the actin cytoskeleton (Burridge and Chrzanowska-Wodnicka, 2003; Pelham and Wang, 1997; Wong et al., 2015), which is required for focal adhesion maturation. As a result, softer substrates can reduce the over-contraction in the MFN2 KO cells. The results support the model that MFN2 KO cells have enhanced cell contraction on the substrates dependent on substrate interaction and force transduction on focal adhesions.</p><disp-quote content-type="editor-comment"><p>Should the authors qualify some of their claims as preliminary or speculative, or remove them altogether?</p></disp-quote><p>We have removed the MFN2-related disease from the introduction to focus the paper more on cell biology in vitro.</p><disp-quote content-type="editor-comment"><p>– There were a number of findings that did not seem to fit in with the paper, or they were included, but were not robustly described nor quantified. As an example, Paxillin-positive focal adhesions were evaluated in MFN2-/- and with various pharmacological approaches, but there is no quantification with respect to size, number, or distribution of focal adhesions, despite language in the main text that there are differences between conditions.</p></disp-quote><p>We have quantified the focal adhesions in the KO cells, and the data is now included in Figure 5. We used the actin distribution to quantify the “PAB”; therefore, FAs are not a significant focus of this study.</p><disp-quote content-type="editor-comment"><p>Also, the model was presented in figure 5, and then there were several pieces of data presented afterward, some that are included in the model (myosin regulation), and some that are not in the model (membrane tension, TFM, substrate stiffness, etc).</p></disp-quote><p>Membrane tension and substrate stiffness dependence are physical properties of the cell. The model focuses on the molecular mechanism that leads to PAB formation.</p><disp-quote content-type="editor-comment"><p>The stiffness/tension figure was not clear to me, and it was difficult to make sense of the data since one would predict that an increase in actomyosin contractility at the cortex would lead to higher membrane tension, not lower, and then how membrane tension relates to spreading on soft matrices is also unclear.</p></disp-quote><p>The result was surprising to us initially. However, the MFN2 KO cells have increased actomyosin contractility only at the cell-substrate interface but not throughout the entire cell cortex. A less spread cell would have a more relaxed membrane and display a lower membrane tension, consistent with our observation. Softer matrices reduce cell contractility at the cell-substrate interface, which allows MFN2 KO cells to relax and spread better. We have emphasized in the discussion of our manuscript that MFN2 KO cells have an increase in actomyosin contractility only at the cell-substrate interface.</p><disp-quote content-type="editor-comment"><p>The manuscript seems like an amalgamation of different pieces of data that do not necessarily fit together into a cohesive story, so the authors are encouraged to either remove these data, or shore them up and weave them into the narrative.</p></disp-quote><p>We respectfully disagree with the reviewer since the cell morphology, actin structure, substrate interaction, and cell mechanics are tightly correlative and provide a complete picture of the role of MFN2 in regulating cell behavior.</p><disp-quote content-type="editor-comment"><p>Request additional experiments</p><p>1. The imaging used for a lot of the quantification (migration, circularity) is difficult to resolve. The cells often look like they are not imaged in the correct imaging plane. It would be helpful to have better representative images such that it is clear how the cells were tracked and how cell periphery regions of interest were manually drawn. Focal adhesions should also be shown without thresholding.</p></disp-quote><p>We used a TIRF microscope and imaged a Z stack. Imaris was used to combine the Z-stack images. The images in the manuscripts are now of the lowest stack with background subtraction.</p><disp-quote content-type="editor-comment"><p>2. For most of the quantification, it appears that the experiment was only performed once and that a handful of cells were quantified. The figure legend indicates the number of cells (often reported as &gt;12 cells or &gt;25 cells), but the methods indicate that high content imaging was performed, and so the interpretation is that these experiments were only performed once. Biological replicates are required. If the data do represent at least 3 biological replicates, then more cell quantification is required (12 or 25 cells in total would mean quantifying a small number of cells per replicate).</p></disp-quote><p>We quantified more cells and indicated the number of cells quantified in the figure legends. The experiments are with three biological replicates.</p><disp-quote content-type="editor-comment"><p>3. Mitochondrial morphology and quantification should be performed in the MFN2 knockdown and rescue lines.</p></disp-quote><p>Mitochondrial morphology is well characterized in the Mfn2 KO and rescue MEF cells (Chen et al., 2003; Naon et al., 2016; Samanas et al., 2020). We observed a similar phenotype using mito-RFP to label mitochondrial structure (Figure S1).</p><disp-quote content-type="editor-comment"><p>4.Many of the comparisons throughout the figures is between MFN2 knockdown and MFN2 knockdown plus rescue or genetic/pharmacological approaches, but a comparison that is rarely made is between wildtype and experimental. These comparisons could be useful in comparing partial rescues and potential redundancies with the other mitofusin.</p></disp-quote><p>We have included the WT in our assays (Figure 2-6). We also confirmed that MFN1 could not rescue the MFN2 defects (Figure 2). We observed partial and complete rescue in different assays. It would be difficult to conclude whether the phenotype is due to the redundancies with the other mitofusin because not all cells are rescued at the endogenous level.</p><disp-quote content-type="editor-comment"><p>5. For the mito/ER tethering experiments, it is important to show that ER/mito contacts are formed and not formed in the various conditions with imaging approaches.</p></disp-quote><p>We adopted a previously established method to quantify ER-mitochondria contacts with the probe SPLICSL (Cieri et al., 2017; Vallese et al., 2020). Our results align with previous reports that Mfn2-null MEFs displayed significantly decreased ER-mitochondria contacts. MFN2 re-expression or ER-mitochondria tethering structure restored the contacts. (Figure S3).</p><disp-quote content-type="editor-comment"><p>6. For some of the pharmacological perturbations, it would be helpful to show that the perturbation actually led to the expected phenotype – as an example, in cells treated with different concentrations of A23187, what are the intracellular calcium levels and how do these treatments influence PAB formation? This aspect should be generally applied across the study – when a modification is made, that particular phenotype should first be evaluated, before dissecting how the perturbation affects downstream phenotypes.</p></disp-quote><p>We selected a collection of well-characterized inhibitors broadly used in the literature for pharmacological perturbations. For example, numerous studies used A23187 treatment to raise intracellular calcium to examine related actin cytoskeleton changes (Carson et al., 1994; Goldfine et al., 1981; Shao et al., 2015). We titrated the drugs in WT in preliminary experiments and observed similar phenotypes. (data not shown). We then use the same concentration to treat the MFN2 KO cells. Overall, we use pharmacological perturbations as supporting evidence. We use genetics (knockdown or overexpression) to validate our results.</p><disp-quote content-type="editor-comment"><p>7. In Figures 4 and 5, the thresholding approaches in the images make the focal adhesions difficult to resolve, and therefore it is difficult to determine the size. As described above, these metrics should be defined and quantified.</p></disp-quote><p>We used a TIRF microscope and imaged a Z stack. Imaris was used to combine the Z-stack images. The images in the manuscripts are now of the lowest stack with background subtraction.</p><disp-quote content-type="editor-comment"><p>8. What is a PAB? How is it defined? What metrics make a structure a PAB versus regular cortical actin – are there quantifiable metrics? In figure 8, there are some structures that are labelled as a PAB, but some aren't (as an example, the left panel in 8b is a PAB, but the right panel in 8A is not, but they look the same), so a PAB should be defined with quantifiable measures, and then applied to the entire study.</p></disp-quote><p>We developed an algorism to quantify PAB cells. We first used the ImageJ plugin FiloQuant (Jacquemet et al., 2019) to identify the cell border and cytoskeleton, then used our custom algorism to quantify the percentage of actin in the cell border area. The cellular circularity is also calculated at the same time. If the cell contains more than 50% actin in the cell border area, and the circularity is higher than 0.6, we then count it as a “PAB” cell (Figure S2).</p><disp-quote content-type="editor-comment"><p>9. As described above, why does RhoA activation not influence cell size and circularity? Can you overexpress MRLC-GFP and inhibit Rho and restore the wildtype phenotype?</p></disp-quote><p>Rho activation usually leads to the formation of more stress fibers and therefore does not lead to decreased cell size and increased circularity observed in MFN2 KO.</p><p>We are sorry that we don’t understand the rationale of this experiment proposed by the reviewer. ROCK inhibition restored the wildtype phenotype in MFN2 KO cells (Figure 7). Figure 8 is to create the MFN2 KO phenotype in WT cells, which requires both Rho and MRLC overactivation.</p><disp-quote content-type="editor-comment"><p>10. Are the data and the methods presented in such a way that they can be reproduced?</p><p>-We appreciate that the authors quantified many parameters, although some quantifications were missing. There are some missing methods – how was directionality quantified, was migration quantified by selecting the approximate center of cells using MTrackJ or were centroids quantified by outlining cells, for instance. Also, given that some of the phenotypes were somewhat arbitrarily assigned (ie. what constitutes a PAB?), it may be difficult to reproduce these approaches and interpret data appropriately.</p></disp-quote><p>We have clarified directionality quantification methods and other details. We used MTrackJ to track cell migration. And as we mentioned above, we came up with a customized algorithm to quantify PAB cells, which shows the critical effectors in a more quantifiable way.</p><disp-quote content-type="editor-comment"><p>11. Are the experiments adequately replicated and statistical analysis adequate?</p><p>-Unfortunately, while the approximate number of cells was reported, the number of biological replicates were not reported, and therefore, the experimental information and statistical analyses are not adequate.</p></disp-quote><p>We have quantified more cells and indicated the number of repeats and cells quantified in the figure legend.</p><disp-quote content-type="editor-comment"><p>Minor comments:</p><p>Specific experimental issues that are easily addressable.</p><p>12. For some of the graphs – mostly about calcium levels – fold change is shown, but raw values should also be included to determine whether the basal levels of calcium are different across the conditions.</p></disp-quote><p>Δ F/F<sub>0</sub> is the standard method to normalize dye loading in cells for calcium</p><p>concentration measurements (Kijlstra et al., 2015; Zhou et al., 2021).</p><disp-quote content-type="editor-comment"><p>13. Scale bars in every panel should also help make the points clearer.</p></disp-quote><p>We have added scale bars in all panels.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Evidence, reproducibility and clarity (Required)):</p><p>1. Figure 1A: The Mfn1 Western Blot is not of publication quality. Moreover, quantitation is necessary.</p></disp-quote><p>We performed additional western blots, changed the representative images, and quantified the level of knockdown and overexpression (Figure 2 and 7). We did not quantify the WB in Figure 1A since it was to confirm that the Mfn1-/- or Mfn2-/- were knock-out cell lines.</p><disp-quote content-type="editor-comment"><p>2. Figure 1B (as well as Figure 2G and others): the date do not reflect cellular size but instead spread cellular area.</p></disp-quote><p>We thank the reviewer for this suggestion. We have changed all similar descriptions to “Spread Area” in the main text and figures.</p><disp-quote content-type="editor-comment"><p>3. Figure 1C, D: Mfn1-null MEFs appear to be more spindle-shaped than wt cells, yet their circularity tends to be elevated. Do the authors have an explanation?</p></disp-quote><p>The circularity of Mfn1-/- MEFs has a slight increase but is not significant compared to the wt cells. As we observed, Mfn1-/- MEFs have fewer protrusions than wt, which may contribute to the slight increase in its circularity (Figure 5C). However, this is not the focus of this study.</p><disp-quote content-type="editor-comment"><p>4. Figure 2A: The Mfn1 levels in Mfn2-/- + Mfn2 are lower than Mfn2-/-? Does this imply a crosstalk between Mfn1 and Mfn2 expression.</p></disp-quote><p>We agree with the reviewer that a compensatory change in MFN1 expression might happen in Mfn2-/- + MFN2 MEFs. Previous research also indicated crosstalk between MFN1 and MFN2 expression (Sidarala et al., 2022).</p><disp-quote content-type="editor-comment"><p>5. Figure 2H: The authors should provide co-staining of mitochondria and Mfn2 as well.</p></disp-quote><p>Co-staining of mitochondria and MFN2 in Mfn2-/- MEFs or rescue lines has been done in numerous previous studies (Chen et al., 2003; Naon et al., 2016; Samanas et al., 2020). In this work, we transfected our cells with mito-RFP and showed mitochondria changes in Mfn2-/- and rescue MEF cells (Figure S1G).</p><disp-quote content-type="editor-comment"><p>6. Figure 4D-E: Western blots are not of publication quality. Looking at the blots provided in Figure 4D, the reviewer is not convinced with the quantitative data shown in Figure 4E. For instance, the intensity of pCaMKII band for &quot;vec&quot; does not look 3x higher than that of &quot;+MFN2&quot;, whereas that of &quot;+MFN2&quot; looks much higher than that of WT.</p></disp-quote><p>We have performed additional western blots and changed the representative images.</p><disp-quote content-type="editor-comment"><p>7. Figure 5C: The authors should stain for vinculin, which are present in mature FAs only, rather than paxillin which are present in all FAs. This would strengthen the authors' conclusions. Also, FA size should be quantified.</p></disp-quote><p>We have quantified FA size in Figure 5. The maturity of FAs is not a major focus of this study. It is likely that most FAs here are mature since they are connected with stress fibers.</p><disp-quote content-type="editor-comment"><p>8. Figure 6C – Why does the background have a grid and appear grey in color? Also, the cell interior appears in different colors in the different images. The authors should take a z-stack of images and provide the raw image files.</p></disp-quote><p>We used a TIRF microscope and imaged a Z stack. Imaris was used to combine the Z-stack images. The images in the manuscripts are now of the lowest stack with background subtraction.</p><disp-quote content-type="editor-comment"><p>9. Figure 7C: The MLCII Western blot is not of publication quality, and may affect the quantification provided in Figure 7D.</p></disp-quote><p>We have performed additional western blots and changed the representative images.</p><disp-quote content-type="editor-comment"><p>10. Figure 8: Do cell treatments with Rho Activator and MLCK-CA also impair migration velocity similar to Mfn2-null cells?</p></disp-quote><p>Our data indicated that Rho Activator and MRLC induced the “PAB” structure seen in MFN2 KO cells. It is likely that cell migration is impaired here. Spatiotemporal regulation of Rho Activation is important to cell migration, it is known that Rho overactivation can significantly inhibit cell migration (Nobes and Hall, 1999). Showing Rho Activator and MLCK-CA will reduce cell migration will not add new knowledge to the cell migration field. However not all cell migration defects are associated with the PAB. We, therefore, focused on PAB quantification in this figure.</p><disp-quote content-type="editor-comment"><p>11. Figure 9A: The authors claim that wt cells have actin bundles that protrude against the membrane while Mfn2-null cells do not. This does not look convincing as the Mfn2-null actin bundle seem to be pushing against the membrane at the bottom of the image. No quantification is provided. It is unclear what conclusion can be drawn from the super-resolution images.</p></disp-quote><p>We used super-resolution imaging to demonstrate the details of the peripheral actin band (PAB) structure. We have used two boxes to enlarge the regions where membrane parallel actin structures are predominant. The quantification of PAB is provided in other figures.</p><disp-quote content-type="editor-comment"><p>12. Suppl. Figure 5C: The authors should take images using a confocal microscope for cells with Flipper-TR construct, eliminate the background and the cell center to only consider the cell periphery. Nikon TE2000 does not seem to be a confocal microscope.</p></disp-quote><p>The amount of Flipper-TR that MEF cells can take in was limited. With the current signal-to-noise ratio, complete background elimination is not feasible. A confocal microscope is not necessary for Flipper-TR FLIM imaging (García-Calvo et al., 2022).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Evidence, reproducibility and clarity (Required)):</p><p>General Comments (Major)</p><p>1. Data Presentation and analysis:</p><p>The data analysis would benefit from using a method such as Super-Plots to show the data from separate biological repeats and to use N numbers that represent the number of biological repeats rather than the number of cells analysed. Please see the following reference for a suggestion on how to analyse the data:</p><p>Lord SJ, Velle KB, Mullins RD, Fritz-Laylin LK. SuperPlots: Communicating</p><p>reproducibility and variability in cell biology. J Cell Biol. 2020 Jun</p><p>1;219(6):e202001064. doi: 10.1083/jcb.202001064. PMID: 32346721; PMCID:</p><p>PMC7265319.</p></disp-quote><p>We have changed the dot colors to show data from separate biological repeats.</p><disp-quote content-type="editor-comment"><p>2. Another general comment is that many of the experiments show analysis of very few numbers of cells or maybe only one field of view in a microscopy quantification experiment. This seems unusually low – for example, in Figure 1E only 6 cells have been analysed. It seems like more could have been done and if statistical analysis like we suggest in 1 above is used, this might reveal that some of the differences are less significant than the authors think/report. This is important, as cells are noisy and it is unusual to have such high significance for experiments like cell migration and other parameters unless a lot of measurements are made. In Figure 1G, it appears that only one field of view has been used to quantify the data. We routinely use 3-5 fields of view to get a representative sample of what the cells are doing.</p></disp-quote><p>We have quantified more cells and indicated the number of repeats and cells quantified in the figure legend.</p><disp-quote content-type="editor-comment"><p>3. Some of the micrographs appear to be missing scale bars- e.g. Figure 2H, Figure 8.</p></disp-quote><p>We have included scale bars in the lower right corner of all panels.</p><disp-quote content-type="editor-comment"><p>4. In the cell tracking experiments, only some of the cells in the images appear to have been tracked. How were the tracked cells chosen? Normally, we would track every cell to avoid bias in selection.</p></disp-quote><p>We tracked all the cells in the view at the beginning of the experiments.</p><disp-quote content-type="editor-comment"><p>5. The western blot images do not show the molecular size of the bands. Show ladder position.</p></disp-quote><p>We have added bands to show molecular weights.</p><disp-quote content-type="editor-comment"><p>6. Mostly the graphs show individual data points, which is good, but in some cases only a bar is shown- it would be nice to have individual points overlaid on the bars- e.g. Figure 1I, 4E, 5B, 5E, 7B, 7D</p></disp-quote><p>We have updated the graph to show individual points.</p><disp-quote content-type="editor-comment"><p>7. Many of the confocal images look very processed- they have no background and have a hazy black halo around the cell. I am not familiar with the type of processing that was done and I worry that the images are only showing a masked and processed version of the actual data. The authors need to explain what processing they have done and probably also to provide the unprocessed images in a supplementary figure or dataset for readers to see. The methods description is inadequate as it only says Image J was used to process the data.</p></disp-quote><p>We used a TIRF microscope and imaged a Z stack. Imaris was used to combine the Z stack images. The images in the manuscripts are now of the lowest stack with background subtraction.</p><disp-quote content-type="editor-comment"><p>Individual comments on Figures:</p><p>Figure 1:</p><p>See general comments above- consider to use Superplots, more cells and more fields of view in quantifications. Show experimental points in bar graph.</p></disp-quote><p>We have quantified more cells and used super plots to display the data. The number of repeats and cells quantified are indicated in the figure legend.</p><disp-quote content-type="editor-comment"><p>Figure 2:</p><p>In 2E, the colours are very similar for two of the experiments so it is difficult to distinguish them- e.g. the MFN1 vs MFN2 rescue data both appear dark blue.</p></disp-quote><p>We have changed the color for MFN1 rescue to distinguish the two samples better.</p><disp-quote content-type="editor-comment"><p>In 2H are the magnifications really the same for the WT as the +DOX and -DOX? The cell in the WT looks huge. Is this representative? Also, the phalloidin stain looks very spotty on the WT. This seems unusual.</p></disp-quote><p>The images are of the same scale. The Mfn2-/- MEFs are smaller, and DOX-induced MFN2 expression can only partially rescue the cell size.</p><disp-quote content-type="editor-comment"><p>Figure 3:</p><p>Not many cells were analysed in 3B, especially the zero time point.</p></disp-quote><p>We have quantified more cells.</p><disp-quote content-type="editor-comment"><p>Please define +T, we assume it is the tether construct, but it is not defined</p></disp-quote><p>We defined T as a tether in the main text and the figure legend.</p><disp-quote content-type="editor-comment"><p>In 3F, how were the tracked cells chosen?</p></disp-quote><p>We tracked all the cells in the view at the beginning of the experiments.</p><disp-quote content-type="editor-comment"><p>Figure 4:</p><p>4B: Why have they not tested FK506 and STO609 on the WT cells?</p></disp-quote><p>We focused on understanding the MFN2 KO phenotype. Since neither FK506 nor STO609 altered the MFN2 KO phenotype, we did not include them in the WT group.</p><disp-quote content-type="editor-comment"><p>4C: How were the tracked cells chosen?</p></disp-quote><p>We tracked all the cells in the view at the start of the experiments.</p><disp-quote content-type="editor-comment"><p>4D-E: The blot doesn't look representative of the quantification- were the numbers normalised to vinculin? The difference between WT and vector looks too large to be real if the amounts were normalised to the vinculin, as vinculin is increased in vector. Likewise, the pCAMKII looks to be substantially decreased from the +MFN2, but this is not what the quantification shows.</p></disp-quote><p>We have performed additional western blots and changed the representative images.</p><disp-quote content-type="editor-comment"><p>Figure 5:</p><p>5B- please clarify which ratio is shown here. I assume it is the ratio of RhoA-GTP vs RhoA between the zero and 4 minute time points.</p></disp-quote><p>Yes, we have clarified this point in the figure legend.</p><disp-quote content-type="editor-comment"><p>5C- These images appear to have a mask around the cell. It is hard to tell where the edge of the cell really is- what sort of processing was used? Especially for the paxillin staining, why is there no cytoplasm shown? Is this because the image is in TIRF?</p></disp-quote><p>We used a TIRF microscope and imaged a Z stack. Imaris was used to combine the Z-stack images. The images in the manuscripts are now of the lowest stack with background subtraction.</p><disp-quote content-type="editor-comment"><p>Figure 6:</p><p>Figure 6C- the blebbistatin treated cell looks very large- is this representative?</p></disp-quote><p>Yes, Blebbistatin-treated cells are larger (Figure 6A).</p><disp-quote content-type="editor-comment"><p>Figure 7:</p><p>Figure 7C- The lanes for MLCII are all run together- is this from a different gel? Is this quantification accurate?</p></disp-quote><p>We have performed additional western blots and changed the representative images.</p><disp-quote content-type="editor-comment"><p>Figure 7F- What is the % level of knockdown achieved?</p></disp-quote><p>The level of knockdown is labeled on the figure.</p><disp-quote content-type="editor-comment"><p>Figure 8:</p><p>Figure 8A,B- does the scale bar represent all of the images in these two panels?</p></disp-quote><p>Yes, the figure legend is updated to clarify this point.</p><disp-quote content-type="editor-comment"><p>Figure 8C,D- Superplots would be helpful here.</p></disp-quote><p>We have used super plots to display the data.</p><disp-quote content-type="editor-comment"><p>Supplementary Data:</p><p>The OCR data do not add much and are not discussed much in the manuscript. Perhaps they could be omitted.</p></disp-quote><p>Our OCR data ruled out the possibility of metabolic regulation. Since MFN2 is a mitochondria protein with its typical functions in metabolic pathways, we cannot omit its influence on metabolism here. As we observed, shMLCK enhanced OCR, shROCK reduced OCR, and both knock-down rescued cell morphology and motility. We believe that PAB formation is independent of MFN2’s function in metabolic regulation.</p><disp-quote content-type="editor-comment"><p>Figure S3- The figure label doesn't match the manuscript test- was fibrinogen or collagen used?</p></disp-quote><p>We tried cover glass alone, collagen, and fibronectin-coated glass. The PAB formation is independent of these extracellular substrates. We did not try fibrinogen because MEF cell is reported to prefer fibronectin (Lehtimäki et al., 2021).</p><p>Reference</p><p>Burridge, K., and Chrzanowska-Wodnicka, M. (2003). FOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING. Http://Dx.Doi.Org/10.1146/Annurev.Cellbio.12.1.463, 12, 463–519. https://doi.org/10.1146/ANNUREV.CELLBIO.12.1.463</p><p>Carson, S. D., Perry, G. A., and Pirruccello, S. J. (1994). Fibroblast Tissue Factor: Calcium and Ionophore Induce Shape Changes, Release of Membrane Vesicles, and Redistribution of Tissue Factor Antigen in Addition to Increased Procoagulant Activity. Blood, 84(2), 526–534. https://doi.org/10.1182/BLOOD.V84.2.526.526</p><p>Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., and Chan, D. C. (2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. The Journal of Cell Biology, 160(2), 189. https://doi.org/10.1083/JCB.200211046</p><p>Cieri, D., Vicario, M., Giacomello, M., Vallese, F., Filadi, R., Wagner, T., Pozzan, T., Pizzo, P., Scorrano, L., Brini, M., and Calì, T. (2017). SPLICS: a split green fluorescent protein-based contact site sensor for narrow and wide heterotypic organelle juxtaposition. Cell Death and Differentiation 2018 25:6, 25(6), 1131–1145. https://doi.org/10.1038/s41418-017-0033-z</p><p>García-Calvo, J., López-Andarias, J., Maillard, J., Mercier, V., Roffay, C., Roux, A., Fürstenberg, A., Sakai, N., and Matile, S. (2022). HydroFlipper membrane tension probes: imaging membrane hydration and mechanical compression simultaneously in living cells. Chemical Science, 13(7), 2086–2093. https://doi.org/10.1039/D1SC05208J</p><p>Goldfine, S. M., Schroter, E. H., and Izzard, C. S. (1981). Calcium-dependent shortening of fibroblasts induced by the ionophore, A23187. Journal of Cell Science, 50(1), 391–405. https://doi.org/10.1242/JCS.50.1.391</p><p>Ikebe, M., and Hartshorne, D. J. (1985). Phosphorylation of Smooth Muscle Myosin at Two Distinct Sites by Myosin Light Chain Kinase*. Journal of Biological Chemistry, 260, 10027–10031. https://doi.org/10.1016/S0021-9258(17)39206-2</p><p>Isotani, E., Zhi, G., Lau, K. S., Huang, J., Mizuno, Y., Persechini, A., Geguchadze, R., Kamm, K. E., and Stull, J. T. (2004). Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proceedings of the National Academy of Sciences of the United States of America, 101(16), 6279–6284. https://doi.org/10.1073/PNAS.0308742101</p><p>Kijlstra, J. D., Hu, D., Mittal, N., Kausel, E., van der Meer, P., Garakani, A., and Domian, I. J. (2015). Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes. Stem Cell Reports, 5(6), 1226. https://doi.org/10.1016/J.STEMCR.2015.10.017</p><p>Lehtimäki, J. I., Rajakylä, E. K., Tojkander, S., and Lappalainen, P. (2021). Generation of stress fibers through myosin-driven reorganization of the actin cortex. <italic>ELife</italic>, 10, 1–43. https://doi.org/10.7554/<italic>ELIFE</italic>.60710</p><p>Naon, D., Zaninello, M., Giacomello, M., Varanita, T., Grespi, F., Lakshminaranayan, S., Serafini, A., Semenzato, M., Herkenne, S., Hernández-Alvarez, M. I., Zorzano, A., De Stefani, D., Dorn, G. W., and Scorrano, L. (2016). Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether. Proceedings of the National Academy of Sciences of the United States of America, 113(40), 11249–11254. https://doi.org/10.1073/PNAS.1606786113/SUPPL_FILE/PNAS.201606786SI.PDF</p><p>Nobes, C. D., and Hall, A. (1999). Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement. The Journal of Cell Biology, 144(6), 1235. https://doi.org/10.1083/JCB.144.6.1235</p><p>Pelham, R. J., and Wang, Y. L. (1997). Cell locomotion and focal adhesions are regulated by substrate flexibility. Proceedings of the National Academy of Sciences of the United States of America, 94(25), 13661. https://doi.org/10.1073/PNAS.94.25.13661</p><p>Samanas, N. B., Engelhart, E. A., and Hoppins, S. (2020). Defective nucleotide-dependent assembly and membrane fusion in Mfn2 CMT2A variants improved by Bax. Life Science Alliance, 3(5). https://doi.org/10.26508/LSA.201900527</p><p>Shao, X., Li, Q., Mogilner, A., Bershadsky, A. D., and Shivashankar, G. V. (2015). Mechanical stimulation induces formin-dependent assembly of a perinuclear actin rim. Proceedings of the National Academy of Sciences of the United States of America, 112(20), E2595–E2601. https://doi.org/10.1073/PNAS.1504837112/SUPPL_FILE/PNAS.1504837112.SM03.AVI</p><p>Sidarala, V., Zhu, J., Levi-D’Ancona, E., Pearson, G. L., Reck, E. C., Walker, E. M., Kaufman, B. A., and Soleimanpour, S. A. (2022). Mitofusin 1 and 2 regulation of mitochondrial DNA content is a critical determinant of glucose homeostasis. Nature Communications 2022 13:1, 13(1), 1–16. https://doi.org/10.1038/s41467-022-29945-7</p><p>Vallese, F., Catoni, C., Cieri, D., Barazzuol, L., Ramirez, O., Calore, V., Bonora, M., Giamogante, F., Pinton, P., Brini, M., and Calì, T. (2020). An expanded palette of improved SPLICS reporters detects multiple organelle contacts in vitro and in vivo. Nature Communications, 11(1). https://doi.org/10.1038/S41467-020-19892-6</p><p>Wong, S. Y., Ulrich, T. A., Deleyrolle, L. P., MacKay, J. L., Lin, J. M. G., Martuscello, R. T., Jundi, M. A., Reynolds, B. A., and Kumar, S. (2015). Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion. Cancer Research, 75(6), 1113–1122. https://doi.org/10.1158/0008-5472.CAN-13-3426</p><p>Zhou, W., Hsu, A. Y., Wang, Y., Syahirah, R., Wang, T., Jeffries, J., Wang, X., Mohammad, H., Seleem, M. N., Umulis, D., and Deng, Q. (2021). Mitofusin 2 regulates neutrophil adhesive migration and the actin cytoskeleton. Journal of Cell Science, 133(17). https://doi.org/10.1242/JCS.248880/VIDEO-11</p></body></sub-article></article>